US5831066A
(en)
*
|
1988-12-22 |
1998-11-03 |
The Trustees Of The University Of Pennsylvania |
Regulation of bcl-2 gene expression
|
US5639595A
(en)
*
|
1990-05-01 |
1997-06-17 |
Isis Phamaceuticals, Inc. |
Identification of novel drugs and reagents
|
US6395888B1
(en)
|
1996-02-01 |
2002-05-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands of complement system proteins
|
US20040132067A1
(en)
*
|
1990-06-11 |
2004-07-08 |
Somalogic, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US5869641A
(en)
*
|
1990-06-11 |
1999-02-09 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of CD4
|
US5683867A
(en)
*
|
1990-06-11 |
1997-11-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: blended SELEX
|
US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US6232071B1
(en)
|
1990-06-11 |
2001-05-15 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US5503978A
(en)
*
|
1990-06-11 |
1996-04-02 |
University Research Corporation |
Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
|
US5476766A
(en)
*
|
1990-06-11 |
1995-12-19 |
Nexstar Pharmaceuticals, Inc. |
Ligands of thrombin
|
US20060084797A1
(en)
*
|
1990-06-11 |
2006-04-20 |
Gilead Sciences, Inc. |
High affinity TGFbeta nucleic acid ligands and inhibitors
|
US6177557B1
(en)
|
1990-06-11 |
2001-01-23 |
Nexstar Pharmaceuticals, Inc. |
High affinity ligands of basic fibroblast growth factor and thrombin
|
US5962219A
(en)
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US5654151A
(en)
*
|
1990-06-11 |
1997-08-05 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV Nucleocapsid nucleic acid ligands
|
US6261774B1
(en)
|
1990-06-11 |
2001-07-17 |
Gilead Sciences, Inc. |
Truncation selex method
|
US5587468A
(en)
*
|
1990-06-11 |
1996-12-24 |
University Research Corporation |
High affinity nucleic acid ligands to HIV integrase
|
US6465189B1
(en)
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Systematic evolution of ligands by exponential enrichment: blended selex
|
US6168778B1
(en)
|
1990-06-11 |
2001-01-02 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes
|
US5674685A
(en)
*
|
1990-06-11 |
1997-10-07 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US5864026A
(en)
*
|
1990-06-11 |
1999-01-26 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
US5972599A
(en)
|
1990-06-11 |
1999-10-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of cytokines
|
US5648214A
(en)
*
|
1990-06-11 |
1997-07-15 |
University Research Corporation |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US5780228A
(en)
*
|
1990-06-11 |
1998-07-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US6147204A
(en)
*
|
1990-06-11 |
2000-11-14 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5668264A
(en)
*
|
1990-06-11 |
1997-09-16 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US5580737A
(en)
*
|
1990-06-11 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
|
US6569620B1
(en)
*
|
1990-06-11 |
2003-05-27 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US6083696A
(en)
*
|
1990-06-11 |
2000-07-04 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands exponential enrichment: blended selex
|
US5635615A
(en)
*
|
1990-06-11 |
1997-06-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity HIV nucleocapsid nucleic acid ligands
|
US6001577A
(en)
*
|
1998-06-08 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex
|
US6344321B1
(en)
*
|
1990-06-11 |
2002-02-05 |
Gilead Sciences, Inc. |
Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met
|
US6331394B1
(en)
|
1991-06-10 |
2001-12-18 |
Gilead Sciences, Inc. |
Nucleic acid ligands to integrins
|
US5637682A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to the tachykinin substance P
|
US6001988A
(en)
*
|
1990-06-11 |
1999-12-14 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands to lectins
|
US6759392B1
(en)
*
|
1990-06-11 |
2004-07-06 |
Gilead Sciences, Inc. |
High affinity RNA ligands of basic fibroblast growth factor
|
US5472841A
(en)
*
|
1990-06-11 |
1995-12-05 |
Nexstar Pharmaceuticals, Inc. |
Methods for identifying nucleic acid ligands of human neutrophil elastase
|
US6011020A
(en)
*
|
1990-06-11 |
2000-01-04 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligand complexes
|
US5795721A
(en)
*
|
1990-06-11 |
1998-08-18 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands of ICP4
|
US5705337A
(en)
*
|
1990-06-11 |
1998-01-06 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US5496938A
(en)
|
1990-06-11 |
1996-03-05 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to HIV-RT and HIV-1 rev
|
US5766853A
(en)
*
|
1990-06-11 |
1998-06-16 |
Nexstar Pharmaceuticals, Inc. |
Method for identification of high affinity nucleic acid ligands to selectins
|
US6346611B1
(en)
|
1990-06-11 |
2002-02-12 |
Gilead Sciences, Inc. |
High affinity TGfβ nucleic acid ligands and inhibitors
|
US5629155A
(en)
*
|
1990-06-11 |
1997-05-13 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US5660985A
(en)
*
|
1990-06-11 |
1997-08-26 |
Nexstar Pharmaceuticals, Inc. |
High affinity nucleic acid ligands containing modified nucleotides
|
US5686592A
(en)
*
|
1990-06-11 |
1997-11-11 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to immunoglobulin E (IgE)
|
US6465188B1
(en)
*
|
1990-06-11 |
2002-10-15 |
Gilead Sciences, Inc. |
Nucleic acid ligand complexes
|
US6716580B2
(en)
|
1990-06-11 |
2004-04-06 |
Somalogic, Inc. |
Method for the automated generation of nucleic acid ligands
|
US5849890A
(en)
*
|
1990-06-11 |
1998-12-15 |
Nexstar Pharmaceuticals, Inc. |
High affinity oligonucleotide ligands to chorionic gonadotropin hormone and related glycoprotein hormones
|
US5707796A
(en)
*
|
1990-06-11 |
1998-01-13 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US5637459A
(en)
*
|
1990-06-11 |
1997-06-10 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chimeric selex
|
US6280932B1
(en)
|
1990-06-11 |
2001-08-28 |
Gilead Sciences, Inc. |
High affinity nucleic acid ligands to lectins
|
US5861254A
(en)
*
|
1997-01-31 |
1999-01-19 |
Nexstar Pharmaceuticals, Inc. |
Flow cell SELEX
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
EP0549692A4
(en)
*
|
1990-09-21 |
1993-08-25 |
Fred Hutchinson Cancer Research Center |
Protein sequence-specific oligonucleotide sequences
|
AU1435492A
(en)
*
|
1991-02-21 |
1992-09-15 |
Gilead Sciences, Inc. |
Aptamer specific for biomolecules and method of making
|
US5840867A
(en)
*
|
1991-02-21 |
1998-11-24 |
Gilead Sciences, Inc. |
Aptamer analogs specific for biomolecules
|
US6762290B1
(en)
|
1999-07-29 |
2004-07-13 |
Gilead Sciences, Inc. |
High affinity vascular endothelial growth factor (VEGF) receptor nucleic acid ligands and inhibitors
|
US5582981A
(en)
*
|
1991-08-14 |
1996-12-10 |
Gilead Sciences, Inc. |
Method for identifying an oligonucleotide aptamer specific for a target
|
AU2580892A
(en)
*
|
1991-09-05 |
1993-04-05 |
Isis Pharmaceuticals, Inc. |
Determination of oligonucleotides for therapeutics, diagnostics and research reagents
|
US5783384A
(en)
*
|
1992-01-13 |
1998-07-21 |
President And Fellows Of Harvard College |
Selection of binding-molecules
|
EP0623141A1
(de)
*
|
1992-01-13 |
1994-11-09 |
The President And Fellows Of Harvard College |
Auswahl von bindungsmolekulen
|
WO2002081494A1
(en)
*
|
2001-03-26 |
2002-10-17 |
Sirna Therapeutics, Inc. |
Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
|
US20040127446A1
(en)
*
|
1992-05-14 |
2004-07-01 |
Lawrence Blatt |
Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication
|
US5756291A
(en)
*
|
1992-08-21 |
1998-05-26 |
Gilead Sciences, Inc. |
Aptamers specific for biomolecules and methods of making
|
WO1994006934A1
(en)
*
|
1992-09-11 |
1994-03-31 |
Duke University |
Method for deriving epitopes
|
US6582902B1
(en)
|
1992-09-30 |
2003-06-24 |
Jack D. Keene |
Method for deriving epitopes
|
JPH08501943A
(ja)
*
|
1992-09-29 |
1996-03-05 |
ネクスター ファーマスーティカルズ,インコーポレイテッド |
核酸リガンドおよびその製造方法
|
CA2146859A1
(en)
*
|
1992-10-14 |
1994-04-28 |
Nexstar Pharmaceuticals, Inc. |
Method for selecting nucleic acids on the basis of structure
|
US5998142A
(en)
*
|
1993-09-08 |
1999-12-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-SELEX
|
EP0724647A4
(de)
*
|
1993-09-08 |
2003-09-17 |
Gilead Sciences Inc |
Nukleinsäureliganden und verbesserte methoden zu ihrer herstellung
|
US6458539B1
(en)
|
1993-09-17 |
2002-10-01 |
Somalogic, Inc. |
Photoselection of nucleic acid ligands
|
DE69435048T2
(de)
*
|
1993-09-17 |
2008-10-02 |
Somalogic, Inc., Boulder |
Systematische evolution von liganden durch exponentielle anreicherung: fotoselektion von nukleinsäureliganden
|
CA2179315A1
(en)
*
|
1993-12-17 |
1995-06-22 |
Roger S. Cubicciotti |
Nucleotide-directed assembly of bimolecular and multimolecular drugs and devices
|
GB9401833D0
(en)
*
|
1994-02-01 |
1994-03-30 |
Isis Innovation |
Method for discovering ligands
|
US7153948B2
(en)
|
1994-04-25 |
2006-12-26 |
Gilead Sciences, Inc. |
High-affinity oligonucleotide ligands to vascular endothelial growth factor (VEGF)
|
US20020077306A1
(en)
*
|
1994-07-14 |
2002-06-20 |
Ludger Dinkelborg |
Conjugates made of metal complexes and oligonucleotides, agents containing the conjugates, their use in radiodiagnosis as well as process for their production
|
IL114237A
(en)
*
|
1994-07-14 |
2000-08-31 |
Schering Ag |
Oligonucleotide conjugates and diagnostic processes utilizing the same
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
US5663064A
(en)
*
|
1995-01-13 |
1997-09-02 |
University Of Vermont |
Ribozymes with RNA protein binding site
|
AU5301996A
(en)
*
|
1995-03-06 |
1996-09-23 |
Nexstar Pharmaceuticals, Inc. |
High-affinity oligonucleotide ligands to secretory phospholipase a2(spla2)
|
US6013443A
(en)
|
1995-05-03 |
2000-01-11 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue SELEX
|
CA2219106C
(en)
|
1995-05-03 |
2008-09-23 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands of tissue target
|
WO1996034875A1
(en)
*
|
1995-05-03 |
1996-11-07 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: tissue selex
|
JP5637528B2
(ja)
*
|
1995-05-04 |
2014-12-10 |
ギリード・サイエンシズ・インコーポレーテッド |
核酸リガンド複合体
|
EP0824541B1
(de)
|
1995-05-04 |
2009-12-16 |
Gilead Sciences, Inc. |
Nukleinsäureligand-komplexe
|
US8071737B2
(en)
|
1995-05-04 |
2011-12-06 |
Glead Sciences, Inc. |
Nucleic acid ligand complexes
|
US5859228A
(en)
*
|
1995-05-04 |
1999-01-12 |
Nexstar Pharmaceuticals, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US5723594A
(en)
*
|
1995-06-07 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
High affinity PDGF nucleic acid ligands
|
US6229002B1
(en)
|
1995-06-07 |
2001-05-08 |
Nexstar Pharmaceuticlas, Inc. |
Platelet derived growth factor (PDGF) nucleic acid ligand complexes
|
ES2321243T3
(es)
*
|
1995-06-07 |
2009-06-03 |
Gilead Sciences, Inc. |
Ligandos de acido nucleico que se unen a las adn polimerasas y las inhiben.
|
US20090118481A1
(en)
*
|
1995-06-07 |
2009-05-07 |
Gilead Sciences, Inc. |
High Affinity Nucleic Acid Ligands To Lectins
|
US6183967B1
(en)
|
1995-06-07 |
2001-02-06 |
Nexstar Pharmaceuticals |
Nucleic acid ligand inhibitors to DNA polymerases
|
US6699843B2
(en)
*
|
1995-06-07 |
2004-03-02 |
Gilead Sciences, Inc. |
Method for treatment of tumors using nucleic acid ligands to PDGF
|
US20040102389A1
(en)
*
|
1995-10-26 |
2004-05-27 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
US20040220128A1
(en)
*
|
1995-10-26 |
2004-11-04 |
Sirna Therapeutics, Inc. |
Nucleic acid based modulation of female reproductive diseases and conditions
|
US20040142895A1
(en)
*
|
1995-10-26 |
2004-07-22 |
Sirna Therapeutics, Inc. |
Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway
|
DE19543750C2
(de)
*
|
1995-11-24 |
1997-10-23 |
Crinos Industria Farmaco |
Cathepsin G inhibierende Aptamere
|
US20020106647A1
(en)
*
|
1996-07-24 |
2002-08-08 |
Segal Andrew H. |
Nucleic acid compositions and methods of introducing nucleic acids into cells
|
US6838238B1
(en)
|
1996-10-17 |
2005-01-04 |
Invitrogen Corporation |
Morphatides: novel shape and structure libraries
|
US20020022227A1
(en)
*
|
1996-10-17 |
2002-02-21 |
Short Jay M. |
Morphatides: novel shape and structure libraries
|
US6051698A
(en)
*
|
1997-06-06 |
2000-04-18 |
Janjic; Nebojsa |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
US6426335B1
(en)
*
|
1997-10-17 |
2002-07-30 |
Gilead Sciences, Inc. |
Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
|
JP2001509828A
(ja)
|
1997-01-08 |
2001-07-24 |
プロリゴ・エルエルシー |
高分子のバイオコンジュゲーション
|
EP0996741A4
(de)
|
1997-01-23 |
2004-06-09 |
Immusol Inc |
Funktionelle genanalyse und genauffindung mit hilfe von willkürlichen oder zielspezifischen ribozym genvektorbibliotheken
|
US6143496A
(en)
|
1997-04-17 |
2000-11-07 |
Cytonix Corporation |
Method of sampling, amplifying and quantifying segment of nucleic acid, polymerase chain reaction assembly having nanoliter-sized sample chambers, and method of filling assembly
|
US5834199A
(en)
*
|
1997-04-29 |
1998-11-10 |
North Carolina State University |
Methods of identifying transition metal complexes that selectively cleave regulatory elements of mRNA and uses thereof
|
CA2220785A1
(en)
*
|
1997-12-02 |
1999-06-02 |
Noureddine Rouissi |
Selective technique for rapid identification of proteins and genes and uses thereof
|
US5989823A
(en)
|
1998-09-18 |
1999-11-23 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US6242246B1
(en)
*
|
1997-12-15 |
2001-06-05 |
Somalogic, Inc. |
Nucleic acid ligand diagnostic Biochip
|
US20070166741A1
(en)
|
1998-12-14 |
2007-07-19 |
Somalogic, Incorporated |
Multiplexed analyses of test samples
|
US6268131B1
(en)
|
1997-12-15 |
2001-07-31 |
Sequenom, Inc. |
Mass spectrometric methods for sequencing nucleic acids
|
US20060057573A1
(en)
*
|
2002-02-15 |
2006-03-16 |
Somalogic, Inc |
Methods and reagents for detecting target binding by nucleic acid ligands
|
AU3909199A
(en)
|
1997-12-15 |
1999-07-05 |
Nexstar Pharmaceuticals, Inc. |
Homogeneous detection of a target through nucleic acid ligand-ligand beacon interaction
|
US6441158B1
(en)
|
1997-12-31 |
2002-08-27 |
Medical College Of Georgia Research Institute, Inc. |
Oligomers that bind to ku protein
|
DE19800899A1
(de)
*
|
1998-01-13 |
1999-07-15 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Oligoliganden mit Bindungsvermögen etc.
|
US6537747B1
(en)
|
1998-02-03 |
2003-03-25 |
Lucent Technologies Inc. |
Data transmission using DNA oligomers
|
US7393529B2
(en)
|
1998-04-09 |
2008-07-01 |
Idexx Laboratories, Inc. |
Methods and compositions for inhibiting binding of IgE to a high affinity receptor
|
US6180348B1
(en)
|
1998-04-20 |
2001-01-30 |
Weihua Li |
Method of isolating target specific oligonucleotide ligands
|
US6287765B1
(en)
*
|
1998-05-20 |
2001-09-11 |
Molecular Machines, Inc. |
Methods for detecting and identifying single molecules
|
US6225063B1
(en)
|
1998-05-22 |
2001-05-01 |
University Technology Corporation |
RNA channels in biological membranes
|
EP1112377A4
(de)
*
|
1998-06-22 |
2004-11-10 |
Univ California |
Nukleinsäure-gekoppelte kolorimetrische analytdetektoren
|
EP1090293B2
(de)
|
1998-06-24 |
2019-01-23 |
Illumina, Inc. |
Dekodierung von matrixartig-angeordneten Sensoren durch Mikropartikel
|
US6100035A
(en)
|
1998-07-14 |
2000-08-08 |
Cistem Molecular Corporation |
Method of identifying cis acting nucleic acid elements
|
US20040259079A1
(en)
*
|
1998-07-22 |
2004-12-23 |
Immusol, Inc. |
Substantially complete ribozyme libraries
|
US6399302B1
(en)
*
|
1998-08-21 |
2002-06-04 |
University Of Virginia Patent Foundation |
Signal generating oligonucleotide-based biosensor
|
US6423493B1
(en)
*
|
1998-10-26 |
2002-07-23 |
Board Of Regents The University Of Texas System |
Combinatorial selection of oligonucleotide aptamers
|
US20060172925A1
(en)
*
|
1998-10-26 |
2006-08-03 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
US20040242521A1
(en)
*
|
1999-10-25 |
2004-12-02 |
Board Of Regents, The University Of Texas System |
Thio-siRNA aptamers
|
EP1002875A1
(de)
*
|
1998-11-17 |
2000-05-24 |
Mira Diagnostica GmbH |
Oligonucleotid Inhibitor von thermostabilen Polymerasen
|
US6927024B2
(en)
*
|
1998-11-30 |
2005-08-09 |
Genentech, Inc. |
PCR assay
|
US7666609B1
(en)
*
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
US6429027B1
(en)
|
1998-12-28 |
2002-08-06 |
Illumina, Inc. |
Composite arrays utilizing microspheres
|
US6858390B2
(en)
*
|
1998-12-31 |
2005-02-22 |
Ingeneus Corporation |
Aptamers containing sequences of nucleic acid or nucleic acid analogues bound homologously, or in novel complexes
|
US20030054360A1
(en)
*
|
1999-01-19 |
2003-03-20 |
Larry Gold |
Method and apparatus for the automated generation of nucleic acid ligands
|
CA2259745A1
(en)
*
|
1999-01-19 |
2000-07-19 |
Guy Tremblay |
Generation of oligonucleotide libraries representative of genomes or expressed mrnas (cdnas) and use thereof
|
KR20010101573A
(ko)
*
|
1999-01-19 |
2001-11-14 |
소마로직, 인크. |
핵산 리간드의 자동 발생을 위한 방법 및 장치
|
US6329145B1
(en)
|
1999-02-09 |
2001-12-11 |
Gilead Science, Inc. |
Determining non-nucleic acid molecule binding to target by competition with nucleic acid ligand
|
US7189506B1
(en)
|
1999-03-03 |
2007-03-13 |
Genelabs Technologies, Inc. |
DNA binding compound-mediated molecular switch system
|
US6794136B1
(en)
|
2000-11-20 |
2004-09-21 |
Sangamo Biosciences, Inc. |
Iterative optimization in the design of binding proteins
|
EP1923472B1
(de)
|
1999-04-20 |
2012-04-11 |
Illumina, Inc. |
Erkennung von Nukleinsäurereaktionen auf Bead-Arrays
|
US20060275782A1
(en)
|
1999-04-20 |
2006-12-07 |
Illumina, Inc. |
Detection of nucleic acid reactions on bead arrays
|
US20030215821A1
(en)
*
|
1999-04-20 |
2003-11-20 |
Kevin Gunderson |
Detection of nucleic acid reactions on bead arrays
|
US6680377B1
(en)
*
|
1999-05-14 |
2004-01-20 |
Brandeis University |
Nucleic acid-based detection
|
US8080380B2
(en)
|
1999-05-21 |
2011-12-20 |
Illumina, Inc. |
Use of microfluidic systems in the detection of target analytes using microsphere arrays
|
US8481268B2
(en)
|
1999-05-21 |
2013-07-09 |
Illumina, Inc. |
Use of microfluidic systems in the detection of target analytes using microsphere arrays
|
US8137906B2
(en)
|
1999-06-07 |
2012-03-20 |
Sloning Biotechnology Gmbh |
Method for the synthesis of DNA fragments
|
US6280943B1
(en)
*
|
1999-06-17 |
2001-08-28 |
Gilead Sciences, Inc. |
2′-fluoropyrimidine anti-calf intestinal phosphatase nucleic acid ligands
|
US7074586B1
(en)
|
1999-06-17 |
2006-07-11 |
Source Precision Medicine, Inc. |
Quantitative assay for low abundance molecules
|
US6303316B1
(en)
|
1999-07-02 |
2001-10-16 |
Conceptual Mind Works, Inc. |
Organic semiconductor recognition complex and system
|
US6387620B1
(en)
*
|
1999-07-28 |
2002-05-14 |
Gilead Sciences, Inc. |
Transcription-free selex
|
US7005260B1
(en)
|
2000-01-28 |
2006-02-28 |
Gilead Sciences, Inc. |
Tenascin-C nucleic acid ligands
|
US6171795B1
(en)
*
|
1999-07-29 |
2001-01-09 |
Nexstar Pharmaceuticals, Inc. |
Nucleic acid ligands to CD40ligand
|
US6506887B1
(en)
*
|
1999-07-29 |
2003-01-14 |
Somalogic, Incorporated |
Conditional-selex
|
EP1078992A3
(de)
*
|
1999-08-26 |
2003-08-27 |
Tomas Antonio Santa Coloma |
Polyklonale und monoklonale Oligokörper (synthetische, auf Oligonukleotiden basierende Antikörper-ähnliche Reagenzien) und Methode zur Herstellung der Oligokörper
|
US7001723B1
(en)
|
1999-11-24 |
2006-02-21 |
The Research Foundation Of State University Of New York |
Catalytic RNAs with aminoacylation activity
|
US6558911B1
(en)
|
1999-12-10 |
2003-05-06 |
Oregon Health Sciences University |
Sperm quality assay
|
CA2328356A1
(en)
*
|
1999-12-22 |
2001-06-22 |
Itty Atcravi |
Recreational vehicles
|
US7645743B2
(en)
*
|
1999-12-22 |
2010-01-12 |
Altermune, Llc |
Chemically programmable immunity
|
US20030087265A1
(en)
*
|
2000-01-21 |
2003-05-08 |
Edward Sauter |
Specific microarrays for breast cancer screening
|
AU2001229637A1
(en)
*
|
2000-01-21 |
2001-07-31 |
Thomas Jefferson University |
Nipple aspirate fluid specific microarrays
|
EP1257668B1
(de)
|
2000-02-16 |
2008-10-29 |
Illumina, Inc. |
Parallele genotypisierung mehrerer patientenproben
|
US20040023292A1
(en)
*
|
2001-10-19 |
2004-02-05 |
Mcswiggen James |
Method and reagent for the detection of proteins and peptides
|
EP2365096A1
(de)
|
2000-03-22 |
2011-09-14 |
Life Technologies Corporation |
Verfahren zur Verwendung von Halbleiternanokristallen in Nukleinsäureassays auf Kügelchenbasis
|
AU2001257012A1
(en)
*
|
2000-04-14 |
2001-10-30 |
Genencor International, Inc. |
Methods for selective targeting
|
US7129326B2
(en)
*
|
2000-04-14 |
2006-10-31 |
Genencor International, Inc. |
Methods for selective targeting
|
US7682837B2
(en)
*
|
2000-05-05 |
2010-03-23 |
Board Of Trustees Of Leland Stanford Junior University |
Devices and methods to form a randomly ordered array of magnetic beads and uses thereof
|
US6471968B1
(en)
|
2000-05-12 |
2002-10-29 |
Regents Of The University Of Michigan |
Multifunctional nanodevice platform
|
US8914114B2
(en)
|
2000-05-23 |
2014-12-16 |
The Feinstein Institute For Medical Research |
Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
|
US20020155084A1
(en)
*
|
2000-06-02 |
2002-10-24 |
The Regents Of The University Of The Michigan |
Nanoemulsion formulations
|
US7892484B2
(en)
*
|
2000-06-30 |
2011-02-22 |
Conceptual Mindworks, Inc. |
Methods and compositions for neutralizing anthrax and other bioagents
|
US20030207271A1
(en)
*
|
2000-06-30 |
2003-11-06 |
Holwitt Eric A. |
Methods and compositions for biological sensors
|
WO2002006827A1
(en)
*
|
2000-07-05 |
2002-01-24 |
The General Hospital Corporation |
Compounds and methods for fluorescently labeling nucleic acids
|
US6376190B1
(en)
|
2000-09-22 |
2002-04-23 |
Somalogic, Inc. |
Modified SELEX processes without purified protein
|
EP1330544A4
(de)
|
2000-09-26 |
2005-04-06 |
Univ Duke |
Rna-aptamere und verfahren zu deren identifizierung
|
DE10049074A1
(de)
*
|
2000-10-02 |
2002-04-18 |
Andreas Kage |
Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren
|
DE10048944A1
(de)
*
|
2000-10-03 |
2002-04-18 |
Andreas Kage |
Verfahren zur Selektion hochaffin an ein Target bindender Nukleinsäuren durch zweidimensionale Auftrennung
|
ATE425457T1
(de)
|
2000-10-06 |
2009-03-15 |
Life Technologies Corp |
Zellen mit spektraler signatur sowie verfahren zu ihrer herstellung und nutzung
|
US20050059031A1
(en)
|
2000-10-06 |
2005-03-17 |
Quantum Dot Corporation |
Method for enhancing transport of semiconductor nanocrystals across biological membranes
|
CA2425605A1
(en)
|
2000-10-16 |
2002-04-25 |
Gilead Sciences, Inc. |
Nucleic acid ligands to the prostate specific membrane antigen
|
US20050054942A1
(en)
|
2002-01-22 |
2005-03-10 |
Melker Richard J. |
System and method for therapeutic drug monitoring
|
JP4379561B2
(ja)
*
|
2001-01-30 |
2009-12-09 |
キヤノンファインテック株式会社 |
シート処理装置及びこれを備えた画像形成装置
|
US7115369B2
(en)
*
|
2001-03-15 |
2006-10-03 |
Iowa State University Research Foundation, Inc. |
Functional nucleic acid probes and uses thereof
|
US7807408B2
(en)
*
|
2001-03-19 |
2010-10-05 |
President & Fellows Of Harvard College |
Directed evolution of proteins
|
AU2002257076A1
(en)
|
2001-03-19 |
2002-10-03 |
President And Fellows Of Harvard College |
Nucleic acid shuffling
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
DE10122847A1
(de)
*
|
2001-05-11 |
2002-11-21 |
Noxxon Pharma Ag |
Enterotoxin B bindende Nukleinsäure
|
US20040006035A1
(en)
*
|
2001-05-29 |
2004-01-08 |
Dennis Macejak |
Nucleic acid mediated disruption of HIV fusogenic peptide interactions
|
US20040198682A1
(en)
*
|
2001-11-30 |
2004-10-07 |
Mcswiggen James |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
|
US20050080031A1
(en)
*
|
2001-05-18 |
2005-04-14 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV
|
ATE482227T1
(de)
*
|
2001-05-25 |
2010-10-15 |
Univ Duke |
Modulatoren pharmakologischer mittel
|
EP1390472A4
(de)
*
|
2001-05-29 |
2004-11-17 |
Sirna Therapeutics Inc |
Nukleinsäurebehandlung von krankheiten oder leiden im zusammenhang mit ras-, her2- und hiv-niveaus
|
WO2002096910A1
(en)
|
2001-05-31 |
2002-12-05 |
Medarex, Inc. |
Cytotoxins, prodrugs, linkers and stabilizers useful therefor
|
US8030465B2
(en)
|
2001-06-29 |
2011-10-04 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
AU2775402A
(en)
*
|
2001-06-29 |
2003-01-02 |
Medimolecular Pty Ltd |
Nucleic acid ligands to complex targets
|
SI1446162T1
(sl)
|
2001-08-17 |
2009-04-30 |
Coley Pharm Gmbh |
Kombinacija zaporedja imunostimulatornih oligonukleotidov z izboljšano aktivnostjo
|
NZ531093A
(en)
|
2001-08-17 |
2007-12-21 |
Neose Technologies Inc |
Chemo-enzymatic synthesis of sialylated oligosaccharides
|
WO2003029492A1
(en)
*
|
2001-09-28 |
2003-04-10 |
Justin Gallivan |
Metabolic genes and related methods and compositions
|
FI115343B
(fi)
*
|
2001-10-22 |
2005-04-15 |
Filtronic Lk Oy |
Sisäinen monikaista-antenni
|
US7629456B2
(en)
|
2001-10-26 |
2009-12-08 |
Noxxon Pharma Ag |
Modified L-nucleic acid
|
US20030162190A1
(en)
*
|
2001-11-15 |
2003-08-28 |
Gorenstein David G. |
Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
|
ATE414767T1
(de)
|
2001-11-22 |
2008-12-15 |
Sloning Biotechnology Gmbh |
Nukleinsäure-linker und deren verwendung in der gensynthese
|
US20030219775A1
(en)
*
|
2001-12-14 |
2003-11-27 |
Ward David C. |
Nucleic acid diagnostic reagents and methods for detecting nucleic acids, polynucleotides and oligonucleotides
|
AU2002359761A1
(en)
|
2001-12-18 |
2003-06-30 |
Invenux, Inc. |
Antibiotic compounds
|
US20040002083A1
(en)
*
|
2002-01-29 |
2004-01-01 |
Ye Ding |
Statistical algorithms for folding and target accessibility prediction and design of nucleic acids
|
US7781396B2
(en)
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7499806B2
(en)
*
|
2002-02-14 |
2009-03-03 |
Illumina, Inc. |
Image processing in microsphere arrays
|
JP4464684B2
(ja)
*
|
2002-02-15 |
2010-05-19 |
ザ リサーチ ファウンデイション オブ ステイト ユニバーシティー オブ ニューヨーク アト バッファロー |
広範なtRNAアミノアシル化活性を有するリボザイム
|
JP2005517422A
(ja)
*
|
2002-02-19 |
2005-06-16 |
シンセリカ・コーポレイション |
代替抗体ならびにその調製方法および使用
|
WO2003106476A1
(en)
*
|
2002-02-20 |
2003-12-24 |
Sirna Therapeutics, Inc |
Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity
|
US7591994B2
(en)
|
2002-12-13 |
2009-09-22 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
US20040023415A1
(en)
|
2002-03-05 |
2004-02-05 |
Konstantin Sokolov |
Biospecific contrast agents
|
US20030219801A1
(en)
*
|
2002-03-06 |
2003-11-27 |
Affymetrix, Inc. |
Aptamer base technique for ligand identification
|
US20040018515A1
(en)
*
|
2002-04-03 |
2004-01-29 |
Diener John L. |
Compositions selective for adenosine diphosphate and methods of using same
|
AU2003233243A1
(en)
*
|
2002-05-06 |
2003-11-17 |
Noxxon Pharma Ag |
Method for amplifying nucleic acids
|
JP5213298B2
(ja)
|
2002-05-27 |
2013-06-19 |
ホルム,ペル・ゾンネ |
アデノウイルスおよびそれをコードしている核酸の新たな使用
|
AU2003238772A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Regents Of The University Of Minnesota |
In vitro evaluation of nucleic acid ligands
|
AU2003247576A1
(en)
*
|
2002-06-18 |
2003-12-31 |
Archemix Corp. |
Aptamer-toxin molecules and methods for using same
|
US7767803B2
(en)
|
2002-06-18 |
2010-08-03 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
US20040249130A1
(en)
*
|
2002-06-18 |
2004-12-09 |
Martin Stanton |
Aptamer-toxin molecules and methods for using same
|
US7655790B2
(en)
*
|
2002-07-12 |
2010-02-02 |
Sirna Therapeutics, Inc. |
Deprotection and purification of oligonucleotides and their derivatives
|
US6989442B2
(en)
*
|
2002-07-12 |
2006-01-24 |
Sirna Therapeutics, Inc. |
Deprotection and purification of oligonucleotides and their derivatives
|
AU2003261264B2
(en)
|
2002-07-25 |
2008-12-11 |
Archemix Corp. |
Regulated aptamer therapeutics
|
WO2004013274A2
(en)
*
|
2002-08-01 |
2004-02-12 |
Noxxon Pharma Ag |
Ghrelin binding nucleic acids
|
EP1393742A1
(de)
|
2002-08-14 |
2004-03-03 |
atugen AG |
Verwendung von Protein Kinase N beta
|
CN1674929B
(zh)
|
2002-08-14 |
2013-07-17 |
赛伦斯治疗公司 |
蛋白激酶Nβ的应用
|
WO2004016586A2
(en)
*
|
2002-08-16 |
2004-02-26 |
Board Of Regents The University Of Texas System |
Compositions and methods related to flavivirus envelope protein domain iii antigens
|
DE10241938A1
(de)
*
|
2002-09-10 |
2004-03-25 |
Noxxon Pharma Ag |
Verfahren zur Selektion von Nukleinsäureliganden
|
US7291710B2
(en)
|
2002-09-11 |
2007-11-06 |
University Of Florida Research Foundation, Inc. |
Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
|
US9303262B2
(en)
|
2002-09-17 |
2016-04-05 |
Archemix Llc |
Methods for identifying aptamer regulators
|
EP1546170A4
(de)
|
2002-09-20 |
2007-08-29 |
Univ Yale |
Riboswitche, verfahren zu deren anwendung und zusammensetzungen, die mit riboswitchen verwendet werden
|
EP1551986B1
(de)
*
|
2002-09-30 |
2014-08-27 |
Affymetrix, Inc. |
Polynukleotidsynthese und markierung durch ligation mit kinetischem sampling
|
AU2003274011B2
(en)
|
2002-10-15 |
2010-03-04 |
Intercell Ag |
Nucleic acids coding for adhesion factor of group B streptococcus, adhesion factors of group B streptococcus and further uses thereof
|
AU2003304278B2
(en)
*
|
2002-10-16 |
2009-03-12 |
Board Of Regents Of The University Of Texas System |
Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries
|
ES2319891T3
(es)
|
2002-10-18 |
2009-05-14 |
Silence Therapeutics Ag |
Factor implicado en la metastasis y usos del mismo.
|
GB0225833D0
(en)
*
|
2002-11-06 |
2002-12-11 |
Univ Leeds |
Nucleic acid ligands and uses therefor
|
WO2004047742A2
(en)
*
|
2002-11-21 |
2004-06-10 |
Archemix Corporation |
Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
|
US20050124565A1
(en)
*
|
2002-11-21 |
2005-06-09 |
Diener John L. |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US8039443B2
(en)
*
|
2002-11-21 |
2011-10-18 |
Archemix Corporation |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
ATE411400T1
(de)
|
2002-11-21 |
2008-10-15 |
Epict Technologies |
Verfahren zur verwendung von riboprimern zur strangverdrängungsreplikation von zielsequenzen
|
US8853376B2
(en)
|
2002-11-21 |
2014-10-07 |
Archemix Llc |
Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics
|
US10100316B2
(en)
|
2002-11-21 |
2018-10-16 |
Archemix Llc |
Aptamers comprising CPG motifs
|
CN102584951A
(zh)
|
2002-11-25 |
2012-07-18 |
金克克国际有限公司 |
皮肤或毛发结合肽
|
US20050037394A1
(en)
*
|
2002-12-03 |
2005-02-17 |
Keefe Anthony D. |
Method for in vitro selection of 2'-substituted nucleic acids
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
AU2003300919A1
(en)
|
2002-12-11 |
2004-06-30 |
Coley Pharmaceutical Gmbh |
5' cpg nucleic acids and methods of use
|
US6936496B2
(en)
|
2002-12-20 |
2005-08-30 |
Hewlett-Packard Development Company, L.P. |
Nanowire filament
|
WO2004060791A1
(en)
|
2003-01-07 |
2004-07-22 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
US6943768B2
(en)
|
2003-02-21 |
2005-09-13 |
Xtellus Inc. |
Thermal control system for liquid crystal cell
|
WO2004076678A2
(en)
*
|
2003-02-24 |
2004-09-10 |
Pritest, Inc. |
Translucent solid matrix assay device for microarray analysis
|
US6861251B2
(en)
|
2003-02-24 |
2005-03-01 |
Pritest, Inc. |
Translucent solid matrix assay device for microarray analysis
|
EP2287315A1
(de)
|
2003-03-04 |
2011-02-23 |
Intercell AG |
Streptococcus-pyogenes-Antigene
|
US7140685B2
(en)
*
|
2003-03-11 |
2006-11-28 |
Gardner Kenneth J |
Swivel chair joint
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
CA2520846C
(en)
|
2003-03-31 |
2013-09-24 |
Mcmaster University |
Aptamer selection method
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
AU2004226262A1
(en)
|
2003-03-31 |
2004-10-14 |
Intercell Ag |
Staphylococcus epidermidis antigens
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
EP2298934A1
(de)
|
2003-04-15 |
2011-03-23 |
Intercell AG |
S. pneumoniae Antigene
|
JP2007525177A
(ja)
|
2003-04-21 |
2007-09-06 |
アーケミックス コーポレイション |
血小板由来増殖因子に対する安定化アプタマーおよび腫瘍治療剤としてのそれらの使用
|
US20050250106A1
(en)
*
|
2003-04-24 |
2005-11-10 |
David Epstein |
Gene knock-down by intracellular expression of aptamers
|
EP2275435A3
(de)
|
2003-05-07 |
2011-08-31 |
Intercell AG |
Streptococcus agalactiae antigene I + II
|
WO2004099411A1
(en)
*
|
2003-05-07 |
2004-11-18 |
Novartis Ag |
A method for dissecting the rna secondary structure dependence of rna-ligand interactions
|
CA2526691A1
(en)
*
|
2003-05-23 |
2005-04-28 |
Board Of Regents - The University Of Texas System |
High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens
|
WO2004113495A2
(en)
|
2003-05-23 |
2004-12-29 |
The President And Fellows Of Harvard College |
Rna-based transcriptional regulators
|
US7910523B2
(en)
*
|
2003-05-23 |
2011-03-22 |
Board Of Regents, The University Of Texas System |
Structure based and combinatorially selected oligonucleoside phosphorothioate and phosphorodithioate aptamer targeting AP-1 transcription factors
|
WO2004106367A2
(en)
|
2003-05-30 |
2004-12-09 |
Intercell Ag |
Enterococcus antigens
|
US20050250094A1
(en)
*
|
2003-05-30 |
2005-11-10 |
Nanosphere, Inc. |
Method for detecting analytes based on evanescent illumination and scatter-based detection of nanoparticle probe complexes
|
DE10325152B4
(de)
*
|
2003-05-30 |
2011-07-21 |
Kage, Andreas, Dr., 12207 |
Verfahren zur quantitativen Bestimmung einer unbekannten Menge einer Zielmolekülspezies
|
US7727969B2
(en)
|
2003-06-06 |
2010-06-01 |
Massachusetts Institute Of Technology |
Controlled release nanoparticle having bound oligonucleotide for targeted delivery
|
CN1279056C
(zh)
*
|
2003-06-06 |
2006-10-11 |
马菁 |
肿瘤相关抗原sm5-1的特异性抗体及其应用
|
US20050232926A1
(en)
*
|
2003-06-06 |
2005-10-20 |
Oncomax Acquisition Corp. |
Antibodies specific for cancer associated antigen SM5-1 and uses thereof
|
EP1493810A1
(de)
|
2003-06-30 |
2005-01-05 |
Gentium S.p.A. |
Auf DNA-basierte Aptamere für Cathepsin G
|
WO2005039645A2
(en)
|
2003-07-10 |
2005-05-06 |
Michigan State University |
Sp1 and sp3 targeted cancer therapies and therapeutics
|
EP1648909A4
(de)
*
|
2003-07-24 |
2008-11-12 |
Univ Texas |
Thioaptamere, die die entdeckung von physiologischen pfaden und neue therapeutische strategien ermöglichen
|
EP2311994A1
(de)
|
2003-08-01 |
2011-04-20 |
Life Technologies Corporation |
Zusammensetzungen und Verfahren zur Aufreinigung kurzer RNA-Moleküle und anderer Nukleinsäuren
|
US20050043245A1
(en)
*
|
2003-08-11 |
2005-02-24 |
Siler -Khodr Theresa M. |
Non-mammalian GnRH analogs and uses thereof in the immune system
|
WO2005019249A2
(en)
|
2003-08-15 |
2005-03-03 |
University Of Florida |
Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
|
EP3168304A1
(de)
*
|
2003-08-27 |
2017-05-17 |
Ophthotech Corporation |
Kombinationstherapie zur behandlung neovaskulärer erkrankungen
|
WO2005024042A2
(en)
|
2003-09-04 |
2005-03-17 |
The Regents Of The University Of California |
Aptamers and methods for their in vitro selection and uses thereof
|
US20050064435A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xing Su |
Programmable molecular barcodes
|
EP1663199B1
(de)
*
|
2003-09-25 |
2013-04-03 |
Tel Aviv University Future Technology Development L.P. |
Zusammensetzungen und diese verwendende verfahren zur behandlung von amyloid-bedingten erkrankungen
|
US7803624B2
(en)
|
2003-09-30 |
2010-09-28 |
Cytyc Corporation |
Automated cytological sample classification
|
CA2540472A1
(en)
*
|
2003-09-30 |
2005-04-07 |
The Hospital For Sick Children |
Method of in situ detection of proteins using aptamers
|
WO2005031362A2
(en)
*
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
US7132298B2
(en)
*
|
2003-10-07 |
2006-11-07 |
Hewlett-Packard Development Company, L.P. |
Fabrication of nano-object array
|
US7223611B2
(en)
*
|
2003-10-07 |
2007-05-29 |
Hewlett-Packard Development Company, L.P. |
Fabrication of nanowires
|
OA13282A
(en)
*
|
2003-11-10 |
2007-01-31 |
Noxxon Pharma Ag |
Nucleic acids specifically binding bioactive ghrelin.
|
JP2007511211A
(ja)
|
2003-11-14 |
2007-05-10 |
ホルム,ペル・ゾンネ |
アデノウイルスおよびそれをコードしている核酸の新たな使用
|
WO2005051174A2
(en)
*
|
2003-11-21 |
2005-06-09 |
The Trustees Of Columbia University In The City Of New York |
Nucleic acid aptamer-based compositions and methods
|
US20050123932A1
(en)
*
|
2003-12-09 |
2005-06-09 |
Mekbib Astatke |
Nucleic acid-chelating agent conjugates
|
GB0328448D0
(en)
*
|
2003-12-09 |
2004-01-14 |
Univ Leeds |
Agents for the regulation of transcription via zinc finger proteins
|
EP1692486B1
(de)
*
|
2003-12-12 |
2015-10-28 |
Saint Louis University |
Biosensoren zum nachweis von makromolekülen und anderen analyten
|
US20050147963A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Intel Corporation |
Composite organic-inorganic nanoparticles and methods for use thereof
|
US7361410B2
(en)
*
|
2003-12-29 |
2008-04-22 |
Intel Corporation |
External modification of composite organic inorganic nanoclusters comprising raman active organic compound
|
US20050191665A1
(en)
*
|
2003-12-29 |
2005-09-01 |
Xing Su |
Composite organic-inorganic nanoclusters
|
US20080076119A9
(en)
*
|
2003-12-29 |
2008-03-27 |
Lei Sun |
Composite organic inorganic nanoclusters
|
US7803931B2
(en)
|
2004-02-12 |
2010-09-28 |
Archemix Corp. |
Aptamer therapeutics useful in the treatment of complement-related disorders
|
PT3385384T
(pt)
*
|
2004-02-12 |
2020-06-30 |
Archemix Llc |
Terapêuticas com aptâmeros úteis no tratamento de desordens relacionadas com o complemento
|
US8389710B2
(en)
|
2004-02-27 |
2013-03-05 |
Operational Technologies Corporation |
Therapeutic nucleic acid-3′-conjugates
|
US8318920B2
(en)
*
|
2004-02-27 |
2012-11-27 |
Operational Technologies Corporation |
Therapeutic nucleic acid-3′-conjugates
|
US7910297B2
(en)
*
|
2004-02-27 |
2011-03-22 |
Operational Technologies Corporation |
Therapeutic nucleic acid-3' -conjugates
|
US20060193821A1
(en)
*
|
2004-03-05 |
2006-08-31 |
Diener John L |
Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics
|
CA2557633A1
(en)
*
|
2004-03-05 |
2005-09-22 |
Archemix Corp. |
Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics
|
EP1734941A2
(de)
|
2004-03-25 |
2006-12-27 |
The Feinstein Institute for Medical Research |
Neurale staubinde
|
US10912712B2
(en)
|
2004-03-25 |
2021-02-09 |
The Feinstein Institutes For Medical Research |
Treatment of bleeding by non-invasive stimulation
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US7407738B2
(en)
*
|
2004-04-02 |
2008-08-05 |
Pavel Kornilovich |
Fabrication and use of superlattice
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
WO2005115477A2
(en)
|
2004-04-13 |
2005-12-08 |
Quintessence Biosciences, Inc. |
Non-natural ribonuclease conjugates as cytotoxic agents
|
US20080214489A1
(en)
*
|
2004-04-19 |
2008-09-04 |
Anthony Dominic Keefe |
Aptamer-mediated intracellular delivery of oligonucleotides
|
US20050239134A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
|
AU2005238490B2
(en)
*
|
2004-04-22 |
2010-11-18 |
Tobira Therapeutics, Inc. |
Improved modulators of coagulation factors
|
US7579450B2
(en)
|
2004-04-26 |
2009-08-25 |
Archemix Corp. |
Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics
|
US7683435B2
(en)
|
2004-04-30 |
2010-03-23 |
Hewlett-Packard Development Company, L.P. |
Misalignment-tolerant multiplexing/demultiplexing architectures
|
DE102004021707A1
(de)
*
|
2004-04-30 |
2005-11-24 |
Cytotools Gmbh |
Verfahren zur Isolierung von spezifischen Molekülen, die hochselektiv an ausgewählte Zielmoleküle binden
|
US7247531B2
(en)
|
2004-04-30 |
2007-07-24 |
Hewlett-Packard Development Company, L.P. |
Field-effect-transistor multiplexing/demultiplexing architectures and methods of forming the same
|
US20060024814A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Peters Kevin F |
Aptamer-functionalized electrochemical sensors and methods of fabricating and using the same
|
EP1781310B1
(de)
|
2004-08-02 |
2015-10-14 |
Ramot at Tel Aviv University Ltd. |
Artikel von peptidnanostrukturen und herstellungsverfahren dafür
|
US20070048797A1
(en)
*
|
2004-08-11 |
2007-03-01 |
Xing Su |
Composite organic inorganic nanoclusters as carriers and identifiers of tester molecules
|
WO2006018850A2
(en)
|
2004-08-19 |
2006-02-23 |
Tel Aviv University Future Technology Development L.P. |
Compositions for treating amyloid associated diseases
|
US20060040258A1
(en)
*
|
2004-08-23 |
2006-02-23 |
Huiyan Guo |
Water-soluble conjugates and methods of preparation
|
US20090104119A1
(en)
*
|
2004-08-25 |
2009-04-23 |
Majoros Istvan J |
Dendrimer Based Compositions And Methods Of Using The Same
|
US7776547B2
(en)
*
|
2004-08-26 |
2010-08-17 |
Intel Corporation |
Cellular analysis using Raman surface scanning
|
US20060046311A1
(en)
*
|
2004-08-26 |
2006-03-02 |
Intel Corporation |
Biomolecule analysis using Raman surface scanning
|
US7566701B2
(en)
|
2004-09-07 |
2009-07-28 |
Archemix Corp. |
Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
|
EP1789096A4
(de)
*
|
2004-09-07 |
2009-07-08 |
Archemix Corp |
Aptamere für den von-willebrand-faktor und ihre verwendung als therapeutika für thrombotische erkrankungen
|
WO2006029258A2
(en)
*
|
2004-09-07 |
2006-03-16 |
Archemix Corp. |
Aptamer medicinal chemistry
|
US7786086B2
(en)
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
US7659091B2
(en)
|
2004-09-21 |
2010-02-09 |
Nourheart, Inc. |
Diagnostic marker
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
MY159370A
(en)
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
EP1804771A2
(de)
*
|
2004-10-28 |
2007-07-11 |
Idexx Laboratories, Inc. |
Zusammensetzungen zur kontrollierten verabreichung pharmazeutisch aktiver zusammensetzungen
|
EP3034089A1
(de)
|
2004-11-02 |
2016-06-22 |
Archemix LLC |
Stabilisierte aptamere für einen aus plättchen gewonnenen wachstumsfaktor und deren verwendung als onkologietherapeutika
|
US9492400B2
(en)
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
US11207518B2
(en)
|
2004-12-27 |
2021-12-28 |
The Feinstein Institutes For Medical Research |
Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
|
EP1833559B1
(de)
|
2004-12-27 |
2010-11-24 |
The Feinstein Institute for Medical Research |
Behandlung von entzündlichen erkrankungen durch elektrische stimulation des vagus-nervs
|
BRPI0519468A2
(pt)
|
2004-12-27 |
2009-01-27 |
Silence Therapeutics Ag |
complexos de lipÍdeos revestido e seu uso
|
US20060147941A1
(en)
*
|
2004-12-30 |
2006-07-06 |
Intel Corporation |
Methods and apparatus for SERS assay of biological analytes
|
US9505846B2
(en)
*
|
2005-01-28 |
2016-11-29 |
Life Technologies Corporation |
Multi-component inhibitors of nucleic acid polymerases
|
US7375012B2
(en)
*
|
2005-02-28 |
2008-05-20 |
Pavel Kornilovich |
Method of forming multilayer film
|
WO2006094014A2
(en)
|
2005-02-28 |
2006-09-08 |
The Regents Of The University Of California |
Methods for diagnosis and treatment of endometrial cancer
|
US20100047338A1
(en)
|
2008-03-14 |
2010-02-25 |
Angela Brodie |
Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
|
AU2006220621A1
(en)
*
|
2005-03-07 |
2006-09-14 |
Archemix Corp. |
Stabilized aptamers to PSMA and their use as prostate cancer therapeutics
|
CN101175769A
(zh)
|
2005-03-10 |
2008-05-07 |
健泰科生物技术公司 |
用于调控血管完整性的方法和组合物
|
US20060205090A1
(en)
*
|
2005-03-14 |
2006-09-14 |
Newton Michael W |
Water-soluble conjugates for electrochemical detection
|
AU2006226844A1
(en)
*
|
2005-03-24 |
2006-09-28 |
Syracuse University |
Elucidation of high affinity, high specificity oligonucleotides and derivatized oligonucleotide sequences for target recognition
|
US20100036106A1
(en)
*
|
2005-03-30 |
2010-02-11 |
Nec Soft, Ltd. |
High-Affinity RNA Aptamer Molecule Against Glutathione-S-Transferase Protein
|
UY29460A1
(es)
*
|
2005-04-08 |
2006-11-30 |
Noxxon Pharma Ag |
Acidos nucleicos de union a ghrelin
|
US8318906B2
(en)
|
2005-04-15 |
2012-11-27 |
The Regents Of The University Of California |
EMP2 antibodies and their therapeutic uses
|
DE102005022057B3
(de)
*
|
2005-05-09 |
2007-02-08 |
Analyticon Biotechnologies Ag |
Verfahren zur Herstellung von Liganden, Liganden und Test-Kit
|
US20060281702A1
(en)
*
|
2005-05-18 |
2006-12-14 |
Board Of Regents, The University Of Texas System |
Combinatorial selection of phosphorothioate aptamers for RNases
|
US8956857B2
(en)
|
2005-06-06 |
2015-02-17 |
Mediomics, Llc |
Three-component biosensors for detecting macromolecules and other analytes
|
US7795009B2
(en)
*
|
2005-06-15 |
2010-09-14 |
Saint Louis University |
Three-component biosensors for detecting macromolecules and other analytes
|
CA2611198C
(en)
*
|
2005-06-10 |
2015-04-28 |
Saint Louis University |
Methods for the selection of aptamers
|
US7811809B2
(en)
*
|
2005-06-15 |
2010-10-12 |
Saint Louis University |
Molecular biosensors for use in competition assays
|
US20070003981A1
(en)
*
|
2005-06-29 |
2007-01-04 |
Rules-Based Medicine, Inc. |
Methods and kits for the diagnosis of acute coronary syndrome
|
US8101385B2
(en)
|
2005-06-30 |
2012-01-24 |
Archemix Corp. |
Materials and methods for the generation of transcripts comprising modified nucleotides
|
MX2007016561A
(es)
|
2005-06-30 |
2008-03-10 |
Archemix Corp |
Materiales y metodos para la generacion de transcriptos de acido nucleico completamente modificados en la posicion 2.
|
WO2007004748A1
(ja)
|
2005-07-05 |
2007-01-11 |
Ribomic Inc. |
免疫グロブリンgに結合する核酸とその利用法
|
US7662571B2
(en)
|
2005-07-14 |
2010-02-16 |
Nourheart Inc. |
Mitochondrial markers of ischemia
|
US20100254901A1
(en)
*
|
2005-07-28 |
2010-10-07 |
Smith Cassandra L |
Compositions comprising nucleic acid aptamers
|
US20070041934A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
US20080279868A1
(en)
|
2005-09-26 |
2008-11-13 |
Medarex, Inc. |
Antibody-Drug Conjugates and Methods of Use
|
EP1973928A2
(de)
|
2005-10-11 |
2008-10-01 |
Ramot at Tel-Aviv University Ltd. |
Selbstzusammengebaute fmoc-ff-hydrogele
|
GB0521139D0
(en)
|
2005-10-18 |
2005-11-23 |
Univ Sheffield |
Therapeutic agent
|
US8168402B2
(en)
*
|
2005-11-03 |
2012-05-01 |
Lohocla Research Corporation |
Diagnostic tests of substance use disorders
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
CA2628451A1
(en)
|
2005-11-04 |
2007-05-18 |
Biogen Idec Ma Inc. |
Methods for promoting neurite outgrowth and survival of dopaminergic neurons
|
US8017159B2
(en)
*
|
2005-11-16 |
2011-09-13 |
Idexx Laboratories, Inc. |
Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same
|
US7754679B2
(en)
*
|
2005-11-16 |
2010-07-13 |
Idexx Laboratories, Inc. |
Pharmaceutical compositions for the administration of aptamers
|
US8114440B2
(en)
*
|
2005-11-16 |
2012-02-14 |
Idexx Laboratories Inc. |
Pharmaceutical compositions for the administration of aptamers
|
US8188260B2
(en)
*
|
2005-12-06 |
2012-05-29 |
The University Of Tokyo |
Versatile acylation catalytic RNAs and uses thereof
|
WO2007070682A2
(en)
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
EP2674440B1
(de)
|
2005-12-16 |
2019-07-03 |
IBC Pharmaceuticals, Inc. |
Polyvalente bioaktive anordnungen auf immunglobulinbasis
|
US20070155022A1
(en)
*
|
2005-12-30 |
2007-07-05 |
Mineo Yamakawa |
Degenerate binding detection and protein identification using Raman spectroscopy nanoparticle labels
|
CA2646833C
(en)
|
2005-12-30 |
2019-07-30 |
Evonik Roehm Gmbh |
Peptides useful as cell-penetrating peptides
|
US20070239483A1
(en)
*
|
2006-01-09 |
2007-10-11 |
Biophysical Corporation |
Methods for individualized health assessment service
|
EP2363205A3
(de)
|
2006-01-11 |
2014-06-04 |
Raindance Technologies, Inc. |
Mikrofluidische Vorrichtungen Und Verfahren Zur Verwendung Bei Der Bildung Und Kontrolle Von Nanoreaktoren
|
SI1994171T1
(sl)
|
2006-01-17 |
2015-07-31 |
Somalogic, Inc. |
Multipleksirane analize testnih vzorcev
|
JP5829373B2
(ja)
|
2006-01-27 |
2015-12-09 |
バイオジェン・エムエイ・インコーポレイテッドBiogen MA Inc. |
Nogoレセプターアンタゴニスト
|
US7922000B2
(en)
*
|
2006-02-15 |
2011-04-12 |
Miraial Co., Ltd. |
Thin plate container with a stack of removable loading trays
|
US8460879B2
(en)
|
2006-02-21 |
2013-06-11 |
The Trustees Of Tufts College |
Methods and arrays for target analyte detection and determination of target analyte concentration in solution
|
HUE026496T2
(en)
|
2006-03-08 |
2016-06-28 |
Archemix Llc |
Complement-binding aptamers and anti-C5 agents for treating eye diseases
|
US8097425B2
(en)
*
|
2006-03-10 |
2012-01-17 |
Tethys Bioscience, Inc. |
Multiplex protein fractionation
|
JP4984990B2
(ja)
*
|
2006-03-28 |
2012-07-25 |
富士通株式会社 |
機能性分子の製造方法
|
US20070231855A1
(en)
*
|
2006-03-28 |
2007-10-04 |
Fujitsu Limited |
Functional molecule and manufacturing method therefor
|
CA2648099C
(en)
|
2006-03-31 |
2012-05-29 |
The Brigham And Women's Hospital, Inc |
System for targeted delivery of therapeutic agents
|
CA2649630C
(en)
|
2006-04-20 |
2016-04-05 |
Silence Therapeutics Ag |
Lipoplex formulations for specific delivery to vascular endothelium
|
WO2007131171A1
(en)
*
|
2006-05-05 |
2007-11-15 |
Rules-Based Medicine, Inc. |
Methods and kits for the diagnosis of hypothyroidism
|
EP2530168B1
(de)
|
2006-05-11 |
2015-09-16 |
Raindance Technologies, Inc. |
Mikrofluidische Vorrichtungen
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
DE202006007590U1
(de)
|
2006-05-12 |
2006-12-14 |
Osaka University |
Verwendung einer Zusammensetzung, die Sema7A- und VLA-1-Interaktion inhibiert, zum Behandeln von Cytokin-vermittelten Erkrankungen
|
WO2007133807A2
(en)
|
2006-05-15 |
2007-11-22 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
US7862812B2
(en)
|
2006-05-31 |
2011-01-04 |
Lpath, Inc. |
Methods for decreasing immune response and treating immune conditions
|
US20070292397A1
(en)
*
|
2006-06-19 |
2007-12-20 |
Mcnulty Amy K |
Method for the detection and neutralization of bacteria
|
WO2007150030A2
(en)
|
2006-06-23 |
2007-12-27 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
JP2009541333A
(ja)
|
2006-06-23 |
2009-11-26 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
修飾リボヌクレアーゼ
|
US20080008694A1
(en)
|
2006-07-05 |
2008-01-10 |
Elgebaly Salwa A |
Methods to prevent and treat diseases
|
EP2049151A4
(de)
|
2006-07-17 |
2010-03-24 |
Quintessence Biosciences Inc |
Verfahren und zusammensetzungen zur behandlung von krebs
|
JP2010500967A
(ja)
|
2006-07-20 |
2010-01-14 |
ザ ジェネラル ホスピタル コーポレイション |
コンビナトリアルターゲティングを通じたプロトキシンの選択的活性化のための方法、組成物、およびキット
|
US7838242B2
(en)
*
|
2006-07-21 |
2010-11-23 |
Hitachi Chemical Co., Ltd. |
Nucleic acid ligands capable of binding to internalin B or internalin A
|
AU2007276388A1
(en)
|
2006-07-21 |
2008-01-24 |
Silence Therapeutics Ag |
Means for inhibiting the expression of protein kinase 3
|
US7645582B2
(en)
*
|
2006-07-21 |
2010-01-12 |
Hitachi Chemical Co., Ltd. |
Aptamers that bind to listeria surface proteins
|
US20080031903A1
(en)
*
|
2006-07-27 |
2008-02-07 |
Andrea Gambotto |
Method of treating ocular infections
|
JP5635772B2
(ja)
*
|
2006-08-01 |
2014-12-03 |
ジェン−プロウブ インコーポレイテッド |
核酸の非特異的標的の捕捉方法
|
AU2007279823A1
(en)
|
2006-08-03 |
2008-02-07 |
Nec Soft, Ltd. |
Method for obtaining oligonucleotide
|
WO2008021123A1
(en)
|
2006-08-07 |
2008-02-21 |
President And Fellows Of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
US20080070802A1
(en)
*
|
2006-08-23 |
2008-03-20 |
Moerschell Richard P |
Directed heterobifunctional linkers
|
AU2007295927A1
(en)
|
2006-09-15 |
2008-03-20 |
Intercell Ag |
Borrelia antigens
|
WO2008045952A2
(en)
*
|
2006-10-10 |
2008-04-17 |
The Regents Of The University Of Michigan |
Photoreceptor precursor cells
|
JP4841396B2
(ja)
|
2006-10-18 |
2011-12-21 |
Necソフト株式会社 |
塩基配列の同定装置、核酸分子の二次構造取得装置、塩基配列の同定方法、核酸分子の二次構造取得方法、プログラム及び記録媒体
|
EP1913955A1
(de)
|
2006-10-19 |
2008-04-23 |
Gerhard, Markus |
Neue Methode zur Behandlung von Infektionen durch H. pylori
|
US7598040B2
(en)
*
|
2006-11-22 |
2009-10-06 |
Trana Discovery, Inc. |
Compositions and methods for the identification of inhibitors of protein synthesis
|
CA2671734A1
(en)
|
2006-12-19 |
2008-06-26 |
Genentech, Inc. |
Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors
|
US20080261253A1
(en)
*
|
2007-01-12 |
2008-10-23 |
Rules-Based Medicine, Inc. |
Methods and kits for the diagnosis of galactosemia
|
US8975026B2
(en)
|
2007-01-16 |
2015-03-10 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US7947447B2
(en)
|
2007-01-16 |
2011-05-24 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US7855054B2
(en)
*
|
2007-01-16 |
2010-12-21 |
Somalogic, Inc. |
Multiplexed analyses of test samples
|
US7964356B2
(en)
|
2007-01-16 |
2011-06-21 |
Somalogic, Inc. |
Method for generating aptamers with improved off-rates
|
US20110136099A1
(en)
|
2007-01-16 |
2011-06-09 |
Somalogic, Inc. |
Multiplexed Analyses of Test Samples
|
US9725713B1
(en)
|
2007-01-22 |
2017-08-08 |
Steven A Benner |
In vitro selection with expanded genetic alphabets
|
US8586303B1
(en)
|
2007-01-22 |
2013-11-19 |
Steven Albert Benner |
In vitro selection with expanded genetic alphabets
|
EP2111553B1
(de)
|
2007-01-24 |
2018-09-19 |
Carnegie Mellon University |
Optische biosensoren
|
WO2008097559A2
(en)
|
2007-02-06 |
2008-08-14 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
WO2008100791A1
(en)
*
|
2007-02-16 |
2008-08-21 |
Rules-Based Medicine, Inc. |
Methods and kits for the diagnosis of sickle cell
|
US20100197510A1
(en)
*
|
2007-03-08 |
2010-08-05 |
Michael Spain |
Methods for rapid disease screening
|
DE102007011702A1
(de)
|
2007-03-08 |
2008-09-11 |
Rheinische Friedrich-Wilhelms Universität |
Aptamer-basierte Reagenzien
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
WO2008124632A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Amphiphilic compound assisted nanoparticles for targeted delivery
|
US20100291562A1
(en)
*
|
2007-04-04 |
2010-11-18 |
Michael Adler |
Method for the detection of an analyte in biological matrix
|
US20080248958A1
(en)
*
|
2007-04-05 |
2008-10-09 |
Hollenbach Andrew D |
System for pulling out regulatory elements in vitro
|
WO2008130623A1
(en)
|
2007-04-19 |
2008-10-30 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
US20090088376A1
(en)
*
|
2007-04-19 |
2009-04-02 |
The Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
CA2684998A1
(en)
|
2007-04-30 |
2009-01-29 |
Nanogen, Inc. |
Multianalyte assay
|
EP2497779A1
(de)
|
2007-05-02 |
2012-09-12 |
Intercell AG |
Klebsiella-Antigene
|
EP2511291A3
(de)
|
2007-06-18 |
2012-11-07 |
Intercell AG |
Chlamydia-Antigene
|
US8828960B2
(en)
*
|
2007-07-17 |
2014-09-09 |
Idexx Laboratories, Inc. |
Amino acid vitamin ester compositions for controlled delivery of pharmaceutically active compounds
|
DK2489743T3
(en)
|
2007-07-17 |
2015-03-02 |
Somalogic Inc |
Aptamers with 5- (N-naphthyl) substituted uridines
|
FR2920024B1
(fr)
|
2007-08-14 |
2012-12-14 |
Lfb Biotechnologies |
Procede de purification ou de detection d'une proteine cible
|
WO2009026540A1
(en)
|
2007-08-22 |
2009-02-26 |
Colorado School Of Mines |
Lanthanide nanoparticle conjugates and uses thereof
|
WO2009029614A1
(en)
|
2007-08-27 |
2009-03-05 |
The Feinstein Institute For Medical Research |
Devices and methods for inhibiting granulocyte activation by neural stimulation
|
DE102007041476B4
(de)
|
2007-08-31 |
2017-03-30 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamere, die an ein an der Hämostase beteiligtes Zielmolekül binden
|
US8198039B2
(en)
*
|
2007-09-04 |
2012-06-12 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Biosensors and related methods
|
US8183221B2
(en)
|
2007-09-05 |
2012-05-22 |
Medtronic, Inc. |
Suppression of SCN9A gene expression and/or function for the treatment of pain
|
US20090068669A1
(en)
*
|
2007-09-12 |
2009-03-12 |
Elias Georges |
Slc9a3r1 directed diagnostics for neoplastic disease
|
CN101855351A
(zh)
*
|
2007-09-14 |
2010-10-06 |
特拉纳探索公司 |
鉴别反转录病毒感染抑制剂的组合物和方法
|
EP2195432B1
(de)
|
2007-09-24 |
2015-12-09 |
Performance Plants, Inc. |
Pflanzen mit erhöhter biomasse
|
WO2009042625A1
(en)
*
|
2007-09-25 |
2009-04-02 |
Idexx Laboratories, Inc. |
Pharmaceutical compositions for administering oligonucleotides
|
AU2008308686B2
(en)
|
2007-10-02 |
2015-01-22 |
Labrador Diagnostics Llc |
Modular point-of-care devices and uses thereof
|
EP2045326A1
(de)
*
|
2007-10-05 |
2009-04-08 |
Bayer CropScience AG |
Verfahren zum Identifizieren des Interaktionspartners eines Wirkstoffes
|
WO2009073063A2
(en)
*
|
2007-10-05 |
2009-06-11 |
The Regents Of The University Of California |
High-stringency screening of target-binding partners using a microfludic device
|
JP2010540681A
(ja)
*
|
2007-10-08 |
2010-12-24 |
クインテッセンス バイオサイエンシズ,インコーポレーテッド |
リボヌクレアーゼに基づく治療のための組成物及び方法
|
WO2011063161A2
(en)
|
2009-11-20 |
2011-05-26 |
The Regents Of The University Of California |
Epithelial membrane protein-2 (emp2) and proliferative vitreoretinopathy (pvr)
|
EP3424525A1
(de)
|
2007-10-12 |
2019-01-09 |
Massachusetts Institute Of Technology |
Impfstoffnanotechnologie
|
US20090163437A1
(en)
*
|
2007-10-16 |
2009-06-25 |
Regado Biosciences, Inc. |
Steady-state subcutaneous administration of aptamers
|
JP2011500076A
(ja)
†
|
2007-10-22 |
2011-01-06 |
プロノタ・エヌブイ |
アプタマーを選択する方法
|
US8906700B2
(en)
|
2007-11-06 |
2014-12-09 |
Ambergen, Inc. |
Methods and compositions for phototransfer
|
WO2009064424A1
(en)
*
|
2007-11-13 |
2009-05-22 |
Rational Affinity Devices, L.L.C. |
Tunable affinity ligands for the separation and detection of target substances
|
CA2706317C
(en)
|
2007-12-03 |
2017-06-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Doc1 compositions and methods for treating cancer
|
EP4053546A1
(de)
|
2007-12-06 |
2022-09-07 |
Genalyte, Inc. |
Vorrichtung und verfahren zur kennzeichnungsfreien überwachung von prozessen.
|
US8865401B2
(en)
|
2007-12-14 |
2014-10-21 |
The Johns Hopkins University |
Purification and concentration of proteins and DNA from a complex sample using isotachophoresis and a device to perform the purification
|
WO2009078939A1
(en)
*
|
2007-12-17 |
2009-06-25 |
Brown University |
Methods for identifying nucleotide ligands
|
JP5550182B2
(ja)
|
2008-01-07 |
2014-07-16 |
ルミネックス コーポレーション |
複合試料マトリクスからの細胞の単離および計数の方法
|
BRPI0906492A2
(pt)
|
2008-01-11 |
2015-12-01 |
Synovex Corp |
antagonistas da caderina-11 e métodos para o tratamento de doenças inflamatórias das articulações
|
US20090233295A1
(en)
*
|
2008-01-29 |
2009-09-17 |
Elias Georges |
Trim59 directed diagnostics for neoplastic disease
|
JP2011511301A
(ja)
|
2008-02-04 |
2011-04-07 |
バンヤン・バイオマーカーズ・インコーポレイテッド |
脳損傷を診断または治療するための方法
|
WO2009151687A2
(en)
|
2008-03-12 |
2009-12-17 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
WO2009151688A2
(en)
*
|
2008-03-12 |
2009-12-17 |
Syracuse University |
Direct selection of structurally defined aptamers
|
US9115352B2
(en)
|
2008-03-31 |
2015-08-25 |
Sloning Biotechnology Gmbh |
Method for the preparation of a nucleic acid library
|
US9211409B2
(en)
|
2008-03-31 |
2015-12-15 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation of T-cell activity
|
US9662490B2
(en)
|
2008-03-31 |
2017-05-30 |
The Feinstein Institute For Medical Research |
Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
|
MX364200B
(es)
|
2008-04-09 |
2019-04-16 |
Genentech Inc |
Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad.
|
JP2011521626A
(ja)
|
2008-05-02 |
2011-07-28 |
エピセンター テクノロジーズ コーポレーション |
Rnaポリホスファターゼの組成物、キットおよびそれらの使用
|
US20110229498A1
(en)
|
2008-05-08 |
2011-09-22 |
The Johns Hopkins University |
Compositions and methods for modulating an immune response
|
US20120003749A1
(en)
*
|
2008-05-21 |
2012-01-05 |
Nec Soft, Ltd. |
Nucleic acid molecule capable of binding to 2,4,6-trinitrophenyl skeleton, method for detecting compound having 2,4,6-trinitrophenyl skeleton using the nucleic acid molecule, and use of the nucleic acid molecule
|
PL2297313T3
(pl)
|
2008-06-06 |
2015-08-31 |
Danisco Us Inc |
Warianty alfa-amylazy z Bacillus subtilis i sposoby ich zastosowania
|
US8722638B2
(en)
*
|
2008-06-20 |
2014-05-13 |
Children's Medical Center Corporation |
Methods for the modulation of angiogenesis
|
AU2009273052B2
(en)
|
2008-07-14 |
2015-09-17 |
The University Of Tokyo |
Aptamer against IL-17 and use thereof
|
ES2437610T3
(es)
|
2008-07-17 |
2014-01-13 |
Ikfe Institut Für Klinische Forschung Und Entwicklung Gmbh |
Biomarcadores para cardiodiabetes
|
US8703416B2
(en)
|
2008-07-17 |
2014-04-22 |
Somalogic, Inc. |
Method for purification and identification of sperm cells
|
WO2010009438A1
(en)
|
2008-07-17 |
2010-01-21 |
Andreas Pfuetzner |
Biomarkers for insulin resistance and beta-cell dysfunction
|
EP4047367A1
(de)
|
2008-07-18 |
2022-08-24 |
Bio-Rad Laboratories, Inc. |
Verfahren zum nachweis von zielanalyten unter verwendung von tropfenbibliotheken
|
ES2665245T3
(es)
*
|
2008-08-11 |
2018-04-25 |
Banyan Biomarkers, Inc. |
Proceso de detección de biomarcador y ensayo de estado neurológico
|
WO2010096464A1
(en)
|
2009-02-18 |
2010-08-26 |
Boyes Stephen G |
Gold/lanthanide nanoparticle conjugates and uses thereof
|
US20100068729A1
(en)
*
|
2008-09-12 |
2010-03-18 |
Rules-Based Medicine, Inc. |
Method and kits for the diagnosis of diabetes
|
MX2011003144A
(es)
|
2008-09-24 |
2011-05-19 |
Ribomic Inc |
Aptamero para factor de crecimiento de nervio y uso del mismo.
|
WO2010036795A2
(en)
*
|
2008-09-29 |
2010-04-01 |
Trana Discovery, Inc. |
Screening methods for identifying specific staphylococcus aureus inhibitors
|
WO2010039861A2
(en)
|
2008-09-30 |
2010-04-08 |
The Regents Of The University Of Michigan |
Dendrimer conjugates
|
JP2012504423A
(ja)
|
2008-10-01 |
2012-02-23 |
クインテッセンス バイオサイエンシズ,インコーポレーテッド |
治療用リボヌクレアーゼ
|
JP2012505243A
(ja)
|
2008-10-09 |
2012-03-01 |
ノースイースタン・ユニバーシティ |
多機能の自己集合性高分子ナノシステム
|
WO2010042933A2
(en)
|
2008-10-10 |
2010-04-15 |
Northwestern University |
Inhibition and treatment of prostate cancer metastasis
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
CN104689316A
(zh)
|
2008-10-22 |
2015-06-10 |
弗·哈夫曼-拉罗切有限公司 |
轴突变性的调节
|
WO2010062627A2
(en)
|
2008-10-27 |
2010-06-03 |
Genalyte Inc. |
Biosensors based on optical probing and sensing
|
CA2742265C
(en)
|
2008-10-29 |
2014-07-15 |
Bg Medicine, Inc. |
Galectin-3 immunoassay
|
DK3199553T3
(da)
|
2008-10-29 |
2019-07-22 |
Circular Commitment Company |
Fremgangsmåder og midler til diagnosticering og behandling af hepatocellulært carcinom
|
WO2010054321A2
(en)
|
2008-11-07 |
2010-05-14 |
The Regents Of The University Of Michigan |
Methods of treating autoimmune disorders and/or inflammatory disorders
|
US8412338B2
(en)
|
2008-11-18 |
2013-04-02 |
Setpoint Medical Corporation |
Devices and methods for optimizing electrode placement for anti-inflamatory stimulation
|
WO2010059820A1
(en)
|
2008-11-21 |
2010-05-27 |
Saint Louis University |
Biosensor for detecting multiple epitopes on a target
|
US20100256196A1
(en)
|
2008-12-04 |
2010-10-07 |
Ikfe |
Biomarkers for Atherosclerosis
|
US20110118134A1
(en)
|
2008-12-11 |
2011-05-19 |
Ikfe Gmbh |
Biomarkers for insulin sensitizer drug response
|
CA2688174C
(en)
|
2008-12-19 |
2018-08-07 |
F. Hoffmann-La Roche Ag |
Dry composition of reaction compounds with stabilized polymerase
|
EP2382467A1
(de)
|
2008-12-30 |
2011-11-02 |
IKFE GmbH |
Biomarker für fettgewebeaktivität
|
US20100210541A1
(en)
|
2009-01-07 |
2010-08-19 |
Andreas Pfuetzner |
Biomarkers for Appetite Regulation
|
CA2761389A1
(en)
|
2009-02-05 |
2010-08-12 |
Tokai Pharmaceuticals, Inc. |
Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
|
EP3939617A1
(de)
|
2009-02-13 |
2022-01-19 |
Immunomedics, Inc. |
Konjugate mit einer intrazellulär spaltbaren bindung
|
EP2405938A2
(de)
|
2009-02-13 |
2012-01-18 |
Intercell AG |
Nicht typisierbare haemophilus influenza-antigene
|
US9249306B2
(en)
|
2009-02-18 |
2016-02-02 |
Carnegie Mellon University |
Quenched dendrimeric dyes for florescence detection
|
FR2942232B1
(fr)
|
2009-02-19 |
2015-03-13 |
Lfb Biotechnologies |
Moyens pour la purification d'une proteine de la coagulation et procedes pour sa mise en oeuvre
|
DK2405928T3
(en)
|
2009-03-11 |
2017-01-30 |
Promedior Inc |
Treatment and diagnosis procedure for hypersensitive diseases
|
WO2010104961A1
(en)
|
2009-03-11 |
2010-09-16 |
Promedior, Inc. |
Treatment methods for autoimmune disorders
|
EP3415235A1
(de)
|
2009-03-23 |
2018-12-19 |
Raindance Technologies Inc. |
Manipulation von mikrofluidiktröpfchen
|
JP5561755B2
(ja)
|
2009-04-01 |
2014-07-30 |
Necソリューションイノベータ株式会社 |
Selex法用のプライマーの設計方法、プライマーの製造方法、アプタマーの製造方法、プライマーの設計装置、プライマー設計用コンピュータプログラムおよび記録媒体
|
US20120121706A1
(en)
|
2009-04-10 |
2012-05-17 |
Tufts Medical Center, Inc. |
PAR-1 Activation by Metalloproteinase-1 (MMP-1)
|
TWI578992B
(zh)
*
|
2009-04-30 |
2017-04-21 |
諾克森製藥股份有限公司 |
與鐵調節激素(hepcidin)結合之核酸類
|
US8996116B2
(en)
|
2009-10-30 |
2015-03-31 |
Setpoint Medical Corporation |
Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
|
US9211410B2
(en)
|
2009-05-01 |
2015-12-15 |
Setpoint Medical Corporation |
Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
|
US9125861B2
(en)
|
2009-05-04 |
2015-09-08 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
PAR2 agonists for use in the treatment or prevention of influenza virus type A infections
|
CN102459298A
(zh)
*
|
2009-05-05 |
2012-05-16 |
阿尔特姆恩科技责任有限公司 |
化学可编程免疫
|
US20100291706A1
(en)
|
2009-05-15 |
2010-11-18 |
Millipore Corporation |
Dye conjugates and methods of use
|
US9551650B2
(en)
|
2009-06-01 |
2017-01-24 |
Cornell University |
Integrated optofluidic system using microspheres
|
JP2012528597A
(ja)
|
2009-06-03 |
2012-11-15 |
レガド・バイオサイエンシズ・インク |
血小板グリコプロテインviの核酸調節因子
|
WO2010141928A2
(en)
|
2009-06-05 |
2010-12-09 |
University Of Florida Research Foundation, Inc. |
Isolation and targeted suppression of lignin biosynthetic genes from sugarcane
|
AU2010258792B2
(en)
|
2009-06-09 |
2015-07-02 |
Setpoint Medical Corporation |
Nerve cuff with pocket for leadless stimulator
|
AR077049A1
(es)
|
2009-06-11 |
2011-07-27 |
Otsuka Pharma Co Ltd |
Aptamero contra quimasa y su uso
|
EP3355059A3
(de)
|
2009-06-19 |
2018-09-26 |
Banyan Biomarkers, Inc. |
Biomarker-assay eines neurologischen zustands
|
US20120156221A1
(en)
|
2009-06-19 |
2012-06-21 |
Ludivine Perrocheau |
Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
|
EP2445334A1
(de)
|
2009-06-26 |
2012-05-02 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Nicht humane tiermodelle für verbesserten netzhautgefässpermeabilität
|
AU2013203588C1
(en)
*
|
2009-07-09 |
2016-06-30 |
Somalogic Operating Co., Inc. |
Method for generating aptamers with improved off-rates
|
WO2011014457A1
(en)
|
2009-07-27 |
2011-02-03 |
Genentech, Inc. |
Combination treatments
|
US9523701B2
(en)
|
2009-07-29 |
2016-12-20 |
Dynex Technologies, Inc. |
Sample plate systems and methods
|
GB0913258D0
(en)
|
2009-07-29 |
2009-09-02 |
Dynex Technologies Inc |
Reagent dispenser
|
FR2948664B1
(fr)
|
2009-07-31 |
2013-11-01 |
Lfb Biotechnologies |
Procede pour la purification de proteines de la coagulation a domaine gla
|
FR2948665B1
(fr)
|
2009-07-31 |
2011-09-23 |
Lfb Biotechnologies |
Procede pour la purification de proteines de la coagulation a domaine gla actives
|
US9250234B2
(en)
|
2011-01-19 |
2016-02-02 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (E-TRACE) immunoassay
|
CA2770071C
(en)
|
2009-08-07 |
2014-07-15 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (e-trace) immunoassay
|
US9624522B2
(en)
|
2009-08-07 |
2017-04-18 |
Ohmx Corporation |
Single, direct detection of hemoglobin A1c percentage using enzyme triggered redox altering chemical elimination (e-trace) immunoassay
|
GB0914318D0
(en)
|
2009-08-14 |
2009-09-30 |
Medical Res Council |
Method
|
US8898069B2
(en)
*
|
2009-08-28 |
2014-11-25 |
The Invention Science Fund I, Llc |
Devices and methods for detecting an analyte in salivary fluid
|
US9024766B2
(en)
*
|
2009-08-28 |
2015-05-05 |
The Invention Science Fund, Llc |
Beverage containers with detection capability
|
WO2011026111A1
(en)
|
2009-08-31 |
2011-03-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Oral delivery of a vaccine to the large intestine to induce mucosal immunity
|
WO2011023824A2
(en)
|
2009-08-31 |
2011-03-03 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Estrogen receptor modulators for the treatment of diseases involving plasmacytoid dendritic cells
|
WO2011032155A2
(en)
|
2009-09-14 |
2011-03-17 |
Banyan Biomarkers, Inc. |
Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury
|
WO2011042564A1
(en)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
WO2011059609A2
(en)
|
2009-10-13 |
2011-05-19 |
The Regents Of The University Of Michigan |
Dendrimer compositions and methods of synthesis
|
AU2010310589A1
(en)
|
2009-10-22 |
2012-05-10 |
Genentech, Inc. |
Modulation of axon degeneration
|
WO2011059586A2
(en)
|
2009-10-30 |
2011-05-19 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
US8236570B2
(en)
|
2009-11-03 |
2012-08-07 |
Infoscitex |
Methods for identifying nucleic acid ligands
|
US8841429B2
(en)
|
2009-11-03 |
2014-09-23 |
Vivonics, Inc. |
Nucleic acid ligands against infectious prions
|
EP2501398A1
(de)
|
2009-11-06 |
2012-09-26 |
INSERM - Institut National de la Santé et de la Recherche Médicale |
Verfahren und pharmazeutische zusammensetzungen zur behandlung von atherosklerose
|
US9833621B2
(en)
|
2011-09-23 |
2017-12-05 |
Setpoint Medical Corporation |
Modulation of sirtuins by vagus nerve stimulation
|
WO2014169145A1
(en)
|
2013-04-10 |
2014-10-16 |
Setpoint Medical Corporation |
Closed-loop vagus nerve stimulation
|
ES2638370T3
(es)
|
2009-11-23 |
2017-10-20 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Inhibidores del complejo PP1/GADD34 para el tratamiento de una afección que requiera una actividad inmunosupresora
|
DE102009056945A1
(de)
|
2009-12-07 |
2011-06-16 |
Christian-Albrechts-Universität Zu Kiel |
DNA-Aptamere, die den löslichen Interleukin-6-Rezeptor spezifisch binden
|
DE102009056944A1
(de)
|
2009-12-07 |
2011-06-09 |
Christian-Albrechts-Universität Zu Kiel |
RNA-Aptamere, die den löslichen Interleukin-6-Rezeptor spezifisch binden
|
EP2517025B1
(de)
|
2009-12-23 |
2019-11-27 |
Bio-Rad Laboratories, Inc. |
Verfahren zur reduzierung des austauschs von molekülen zwischen tröpfchen
|
EP3636314B1
(de)
|
2009-12-23 |
2021-09-08 |
Setpoint Medical Corporation |
Nervenstimulatoren und systeme zur behandlung von chronischer entzündung
|
US20110165037A1
(en)
*
|
2010-01-07 |
2011-07-07 |
Ismagilov Rustem F |
Interfaces that eliminate non-specific adsorption, and introduce specific interactions
|
US9415028B2
(en)
|
2010-01-15 |
2016-08-16 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Compounds for the treatment of autism
|
WO2011091146A1
(en)
|
2010-01-20 |
2011-07-28 |
New England Biolabs, Inc. |
Compositions, methods and related uses for cleaving modified dna
|
US20110201076A1
(en)
|
2010-01-22 |
2011-08-18 |
Colorado School Of Mines |
Harvesting micro algae
|
EP2533798A2
(de)
|
2010-02-09 |
2012-12-19 |
Universität Bremen |
P19arf, hmga2 und mdm2 zur diagnose und behandlung des wachstums von anomalen zellen
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
WO2011099576A1
(ja)
|
2010-02-12 |
2011-08-18 |
国立大学法人 東京大学 |
Fgf2に対するアプタマー及びその使用
|
EP2534267B1
(de)
|
2010-02-12 |
2018-04-11 |
Raindance Technologies, Inc. |
Digitale analyse von analyten
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
EP2534266B1
(de)
|
2010-02-12 |
2016-07-06 |
Saint Louis University |
Molekulare biosensoren zur signalverstärkung
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
JP5981853B2
(ja)
|
2010-02-18 |
2016-08-31 |
ジェネンテック, インコーポレイテッド |
ニューレグリンアンタゴニスト及び癌の治療におけるそれらの使用
|
ES2544635T3
(es)
|
2010-03-01 |
2015-09-02 |
Quanterix Corporation |
Métodos para extender el rango dinámico en ensayos para la detección de moléculas o partículas
|
US8236574B2
(en)
|
2010-03-01 |
2012-08-07 |
Quanterix Corporation |
Ultra-sensitive detection of molecules or particles using beads or other capture objects
|
US9678068B2
(en)
|
2010-03-01 |
2017-06-13 |
Quanterix Corporation |
Ultra-sensitive detection of molecules using dual detection methods
|
CA2808233C
(en)
|
2010-03-03 |
2017-07-11 |
Somalogic, Inc. |
Aptamers to 4-1bb and their use in treating diseases and disorders
|
WO2011113118A1
(en)
|
2010-03-19 |
2011-09-22 |
Katholieke Universiteit Leuven |
Drug tolerance/persistence of fungal biofilms
|
TWI500425B
(zh)
|
2010-03-24 |
2015-09-21 |
Ribomic Inc |
對ngf之適體及其用途
|
US20130029362A1
(en)
|
2010-04-01 |
2013-01-31 |
Andreas Jeromin |
Markers and assays for detection of neurotoxicity
|
PT2555789T
(pt)
|
2010-04-08 |
2020-07-14 |
Inst Nat Sante Rech Med |
Péptidos inibidores derivados do transcrito 1 tipo-trem (tlt-1) e seus usos
|
CN104069512A
(zh)
|
2010-04-12 |
2014-10-01 |
私募蛋白质体公司 |
针对β-NGF的适体及其在治疗β-NGF介导的疾病和失调中的用途
|
EP2577309B1
(de)
|
2010-05-25 |
2016-11-23 |
Carnegie Mellon University |
Gezielte sonden für zellphysiologie
|
EP2589657A4
(de)
*
|
2010-07-01 |
2014-04-23 |
Nat Inst Of Advanced Ind Scien |
Verfahren zum nachweis von zielmolekülen
|
EP2589653A1
(de)
|
2010-07-02 |
2013-05-08 |
NEC Soft, Ltd. |
Vorhersagevorrichtung, vorhersageverfahren, programm und aufzeichnungsmedium
|
CN103153331B
(zh)
|
2010-07-15 |
2017-03-22 |
亚德赫伦医疗公司 |
靶向于钙粘着蛋白‑11的ec1结构域的人源化抗体及相关组合物和方法
|
WO2012016188A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
WO2012019991A1
(en)
|
2010-08-09 |
2012-02-16 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for the treatment of hiv-1 infections
|
CN103228796B
(zh)
|
2010-08-11 |
2016-06-01 |
赛路拉公司 |
基因分型dna
|
WO2012021913A1
(en)
|
2010-08-18 |
2012-02-23 |
University Of Graz |
Methods for increasing resistance of plants to drought, salt and pathogens
|
WO2012022496A2
(en)
|
2010-08-19 |
2012-02-23 |
Per Sonne Holm |
Method for killing tumor stem cells
|
EP2619307A1
(de)
|
2010-09-21 |
2013-07-31 |
RiboxX GmbH |
Verfahren zur synthese von rna mittels dna-templat
|
EP2622104A4
(de)
|
2010-09-27 |
2015-04-15 |
Somalogic Inc |
Biomarker für mesotheliome und verwendungen davon
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
US20120095085A1
(en)
|
2010-10-14 |
2012-04-19 |
Layzer Juliana M |
Nucleic acid modulators of clec-2
|
US9746481B2
(en)
|
2010-10-14 |
2017-08-29 |
The Johns Hopkins University |
Biomarkers of brain injury
|
WO2012061778A2
(en)
|
2010-11-05 |
2012-05-10 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
US9072766B2
(en)
|
2010-11-18 |
2015-07-07 |
Beth Israel Deaconess Medical Center, Inc. |
Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)
|
WO2012090150A2
(en)
|
2010-12-27 |
2012-07-05 |
Compugen Ltd |
New cell-penetrating peptides and uses thereof
|
WO2012095303A1
(en)
|
2011-01-10 |
2012-07-19 |
Noxxon Pharma Ag |
Nucleic acid molecule having binding affinity to a target molecule and a method for generating the same
|
AR085087A1
(es)
|
2011-01-21 |
2013-09-11 |
Theranos Inc |
Sistemas y metodos para maximizar el uso de muestras
|
EP2673301A2
(de)
|
2011-02-09 |
2013-12-18 |
Cancer Research Technology Limited |
Frmd4a-antagonisten und ihre verwendung
|
US9364803B2
(en)
|
2011-02-11 |
2016-06-14 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
US9150852B2
(en)
|
2011-02-18 |
2015-10-06 |
Raindance Technologies, Inc. |
Compositions and methods for molecular labeling
|
WO2012138694A2
(en)
|
2011-04-07 |
2012-10-11 |
Emory University |
Compositions comprising saccharide binding moieties and methods for targeted therapy
|
ES2741282T3
(es)
|
2011-05-05 |
2020-02-10 |
Matinas Biopharma Nanotechnologies Inc |
Composiciones de cocleato y métodos de elaboración y uso de las mismas
|
WO2012152711A1
(en)
|
2011-05-06 |
2012-11-15 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Methods for identifying aptamers
|
EP2707094B1
(de)
|
2011-05-09 |
2016-02-03 |
Setpoint Medical Corporation |
Einzelimpulsaktivierung des cholinergen entzündungshemmenden pfades zur behandlung chronischer entzündungen
|
EP2707389B1
(de)
|
2011-05-12 |
2019-10-30 |
The Johns Hopkins University |
Testreagenzien für eine neurogranin-diagnosekit
|
WO2012156476A2
(en)
|
2011-05-16 |
2012-11-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for screening substances capable of modulating the replication of an influenza virus
|
AR086543A1
(es)
|
2011-05-25 |
2014-01-08 |
Bg Medicine Inc |
Inhibidores de galectina-3 y metodos de uso de los mismos, composicion farmaceutica
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
EP3709018A1
(de)
|
2011-06-02 |
2020-09-16 |
Bio-Rad Laboratories, Inc. |
Mikrofluidische vorrichtung zum nachweis von komponenten einer chemischen reaktion
|
GB201110371D0
(en)
|
2011-06-17 |
2011-08-03 |
Proteome Sciences R & D Gmbh & Co Kg |
Materials and methods for determining sensitivity potential of compounds
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
US20140243391A1
(en)
|
2011-07-22 |
2014-08-28 |
Centre National De La Recherche Scientifique |
Phospholipid-detergent conjugates and uses thereof
|
TW202114735A
(zh)
|
2011-08-01 |
2021-04-16 |
美商建南德克公司 |
利用pd-1軸結合拮抗劑及mek抑制劑治療癌症之方法
|
EP2743349A4
(de)
|
2011-08-12 |
2015-03-25 |
Riken |
Verfahren zur herstellung eines nukleinsäureaptamers
|
GB201114662D0
(en)
|
2011-08-24 |
2011-10-12 |
Altermune Technologies Llc |
Chemically programmable immunity
|
EP2753697A1
(de)
|
2011-09-05 |
2014-07-16 |
ETH Zürich |
Biosynthetischer gencluster zur herstellung von peptid- bzw. protein-analoga
|
WO2013034687A1
(en)
|
2011-09-09 |
2013-03-14 |
Universität Bern Verwaltungsdirektion |
Avibacterium paragallinarum rtx toxin
|
US8435738B2
(en)
|
2011-09-25 |
2013-05-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US9268915B2
(en)
|
2011-09-25 |
2016-02-23 |
Theranos, Inc. |
Systems and methods for diagnosis or treatment
|
US8840838B2
(en)
|
2011-09-25 |
2014-09-23 |
Theranos, Inc. |
Centrifuge configurations
|
US8475739B2
(en)
|
2011-09-25 |
2013-07-02 |
Theranos, Inc. |
Systems and methods for fluid handling
|
US9632102B2
(en)
|
2011-09-25 |
2017-04-25 |
Theranos, Inc. |
Systems and methods for multi-purpose analysis
|
US9664702B2
(en)
|
2011-09-25 |
2017-05-30 |
Theranos, Inc. |
Fluid handling apparatus and configurations
|
US9619627B2
(en)
|
2011-09-25 |
2017-04-11 |
Theranos, Inc. |
Systems and methods for collecting and transmitting assay results
|
US20140170735A1
(en)
|
2011-09-25 |
2014-06-19 |
Elizabeth A. Holmes |
Systems and methods for multi-analysis
|
WO2013040577A1
(en)
|
2011-09-16 |
2013-03-21 |
The Research Foundation Of State University Of New York |
Aptamers resistant to nucleocapsid degradation
|
RU2014114617A
(ru)
|
2011-09-19 |
2015-10-27 |
Дженентек, Инк. |
Комбинированные виды лечения, содержащие антагонисты с-мет и антагонисты b-raf
|
US9810704B2
(en)
|
2013-02-18 |
2017-11-07 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
US10012664B2
(en)
|
2011-09-25 |
2018-07-03 |
Theranos Ip Company, Llc |
Systems and methods for fluid and component handling
|
US9250229B2
(en)
|
2011-09-25 |
2016-02-02 |
Theranos, Inc. |
Systems and methods for multi-analysis
|
AU2012317323B2
(en)
*
|
2011-09-28 |
2017-10-05 |
Fujimoto Pharmaceutical Corporation |
NGF aptamer and application thereof
|
WO2013049405A1
(en)
|
2011-09-30 |
2013-04-04 |
Mallinckrodt Llc |
Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
|
US20140248294A1
(en)
|
2011-10-05 |
2014-09-04 |
University Of Bremen |
Wnt4 and med12 for use in the diagnosis and treatment of tumor diseases
|
WO2013059886A1
(en)
|
2011-10-28 |
2013-05-02 |
Patrys Limited |
Pat-lm1 epitopes and methods for using same
|
EP2773958B1
(de)
|
2011-11-02 |
2017-11-29 |
University of Cape Town |
Verfahren zur identifizierung eines analyts in einer biologischen probe
|
US9340567B2
(en)
|
2011-11-04 |
2016-05-17 |
Ohmx Corporation |
Chemistry used in biosensors
|
WO2013073602A1
(ja)
|
2011-11-18 |
2013-05-23 |
独立行政法人理化学研究所 |
標的タンパク質に結合する核酸断片
|
FR2983212A1
(fr)
|
2011-11-28 |
2013-05-31 |
Lfb Biotechnologies |
Aptameres anti-fh, procede pour leur obtention et utilisations
|
JP2015500013A
(ja)
|
2011-11-30 |
2015-01-05 |
ユニバーシティ オブ ブレーメン |
胎盤組織におけるmiRNAの発現
|
US9402911B2
(en)
|
2011-12-08 |
2016-08-02 |
The Regents Of The University Of Michigan |
Multifunctional small molecules
|
CA2860739A1
(en)
|
2012-01-09 |
2013-07-18 |
Ohmx Corporation |
Enzyme cascade methods for e-trace assay signal amplification
|
KR102138106B1
(ko)
|
2012-01-31 |
2020-07-28 |
더유니버시티오브톨레도 |
피분석물을 검출 및 측정하기 위한 방법 및 장치
|
WO2013119602A1
(en)
|
2012-02-06 |
2013-08-15 |
President And Fellows Of Harvard College |
Arrdc1-mediated microvesicles (armms) and uses thereof
|
FR2987627B1
(fr)
|
2012-03-05 |
2016-03-18 |
Splicos |
Utilisation de rbm39 comme biomarqueur
|
EP3907506A1
(de)
|
2012-03-12 |
2021-11-10 |
The Board of Trustees of the University of Illinois |
Optische analytdetektionssysteme mit magnetischer verstärkung und verfahren zu deren verwendung
|
WO2013142255A2
(en)
|
2012-03-22 |
2013-09-26 |
University Of Miami |
Multi-specific binding agents
|
US9572983B2
(en)
|
2012-03-26 |
2017-02-21 |
Setpoint Medical Corporation |
Devices and methods for modulation of bone erosion
|
WO2013152252A1
(en)
|
2012-04-06 |
2013-10-10 |
OSI Pharmaceuticals, LLC |
Combination anti-cancer therapy
|
WO2013170960A1
(en)
|
2012-05-16 |
2013-11-21 |
Silence Therapeutics Ag |
Use of vegfr1 as a biomarker for pkn3 inhibitor administration
|
AU2013266243A1
(en)
|
2012-05-24 |
2014-12-18 |
Beth Israel Deaconess Medical Center, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
|
KR102088381B1
(ko)
|
2012-06-07 |
2020-03-13 |
소마로직, 인크. |
압타머-기반 다중 검정법
|
US8795359B2
(en)
|
2012-06-13 |
2014-08-05 |
Elwha Llc |
Breast implant with regionalized analyte sensors and internal power source
|
US9144488B2
(en)
|
2012-06-13 |
2015-09-29 |
Elwha Llc |
Breast implant with analyte sensors responsive to external power source
|
US8790400B2
(en)
|
2012-06-13 |
2014-07-29 |
Elwha Llc |
Breast implant with covering and analyte sensors responsive to external power source
|
US9144489B2
(en)
|
2012-06-13 |
2015-09-29 |
Elwha Llc |
Breast implant with covering, analyte sensors and internal power source
|
US9211185B2
(en)
|
2012-06-13 |
2015-12-15 |
Elwha Llc |
Breast implant with analyte sensors and internal power source
|
US8808373B2
(en)
|
2012-06-13 |
2014-08-19 |
Elwha Llc |
Breast implant with regionalized analyte sensors responsive to external power source
|
EP2864345B1
(de)
|
2012-06-25 |
2019-12-11 |
Emory University |
Nukleinsäurepartikelkonjugate und therapeutische anwendungen davon
|
CN104661664B
(zh)
|
2012-07-13 |
2020-07-03 |
波涛生命科学有限公司 |
手性控制
|
WO2014014518A1
(en)
|
2012-07-18 |
2014-01-23 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
JP2015529809A
(ja)
|
2012-07-27 |
2015-10-08 |
オームクス コーポレイション |
酵素及び他の標的分析物の存在及び活性の切断前検出後の単分子層の電気測定
|
EP3121288A1
(de)
|
2012-07-27 |
2017-01-25 |
Ohmx Corporation |
Elektronische messungen von monoschichten nach homogenen reaktionen ihrer komponenten
|
BR112015002287A2
(pt)
|
2012-07-31 |
2017-07-04 |
Joaquin Lopez |
processo para obtenção e detecção de um marcador de objetos a serem identificados, o marcador, método para autenticação e método para verificação
|
BR112015002289A2
(pt)
*
|
2012-08-02 |
2017-07-04 |
Univ Deakin |
aptâmeros cd133 para a detecção de células tronco cancerosas
|
WO2014022852A1
(en)
|
2012-08-03 |
2014-02-06 |
Aptamir Therapeutics, Inc. |
Cell-specific delivery of mirna modulators for the treatment of obesity and related disorders
|
AU2013204200B2
(en)
|
2012-10-11 |
2016-10-20 |
Brandeis University |
Treatment of amyotrophic lateral sclerosis
|
DE102012020496A1
(de)
|
2012-10-18 |
2014-04-24 |
Charité - Universitätsmedizin Berlin |
Biomarker zur Diagnostik und Behandlung von Neurofibromatose Typ 1
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
KR20150090072A
(ko)
|
2012-10-23 |
2015-08-05 |
카리스 라이프 사이언스 스위스 홀딩스 게엠베하 |
압타머 및 이의 용도
|
CA2889415C
(en)
|
2012-10-24 |
2020-06-02 |
Genmark Diagnostics, Inc. |
Integrated multiplex target analysis
|
CA2884313C
(en)
|
2012-12-13 |
2023-01-03 |
Immunomedics, Inc. |
Dosages of immunoconjugates of antibodies and sn-38 for improved efficacy and decreased toxicity
|
WO2014100434A1
(en)
|
2012-12-19 |
2014-06-26 |
Caris Science, Inc. |
Compositions and methods for aptamer screening
|
FR3000105B1
(fr)
*
|
2012-12-24 |
2015-05-15 |
Lvmh Rech |
Aptameres inhibiteurs de l'activite enzymatique de la tyrosinase
|
WO2014121256A1
(en)
|
2013-02-04 |
2014-08-07 |
The Cleveland Clinic Foundation |
Aptamers for tumor initiating cells
|
US20150379197A1
(en)
|
2013-02-15 |
2015-12-31 |
Nec Solution Innovators, Ltd. |
Selection device for candidate sequence information for similarity determination, selection method, and use for such device and method
|
EP2774930A1
(de)
|
2013-03-07 |
2014-09-10 |
Aptenia S.R.L. |
Metallocenverbindungen und markierte Moleküle damit für In-vivo-Bildgebung
|
AU2014236135A1
(en)
|
2013-03-14 |
2015-09-10 |
Thomas Jefferson University |
Androgen receptor down-regulating agents and uses thereof
|
US9052314B2
(en)
|
2013-03-14 |
2015-06-09 |
Silver Lake Research Corporation |
Biomarkers for detecting the presence of bacteria
|
DK3296747T3
(da)
|
2013-03-15 |
2020-03-30 |
Somalogic Inc |
Biomarkører for non-alkoholisk fedtleversygdom (NAFLD) og non-alkoholisk steatohepatitis (NASH) og anvendelser deraf
|
WO2014143637A1
(en)
|
2013-03-15 |
2014-09-18 |
The Board Of Trustees Of The University Of Illinois |
Methods and compositions for enhancing immunoassays
|
JP6683598B2
(ja)
|
2013-03-15 |
2020-04-22 |
マックスサイト インコーポレーティッド |
安定なトランスフェクトされた細胞を生成するための方法および組成物
|
WO2014148638A1
(ja)
|
2013-03-22 |
2014-09-25 |
国立大学法人東京大学 |
Il-17に対するアプタマー及びその使用
|
AU2014241170A1
(en)
|
2013-03-27 |
2015-09-24 |
Theranos Ip Company, Llc |
Methods, devices, and systems for sample analysis
|
WO2014190230A1
(en)
|
2013-05-23 |
2014-11-27 |
Iphenotype Llc |
Phenotypic integrated social search database and method
|
GB201310203D0
(en)
|
2013-06-07 |
2013-07-24 |
Electrophoretics Ltd |
Materials and methods relating to Alzheimer's disease
|
WO2014197965A1
(en)
|
2013-06-12 |
2014-12-18 |
The Governing Council Of The University Of Toronto |
Catalytic nucleic acid and gold nanoparticles for detection of biomolecules
|
ES2754177T3
(es)
|
2013-06-12 |
2020-04-16 |
Massachusetts Gen Hospital |
Métodos para la detección multiplexada de moléculas diana y sus usos
|
CN105308073B
(zh)
|
2013-06-14 |
2019-08-13 |
加利福尼亚太平洋生物科学股份有限公司 |
双生物素化标签
|
SG11201510369WA
(en)
|
2013-06-25 |
2016-01-28 |
Univ Canberra |
Methods and compositions for modulating cancer stem cells
|
EP3014264A4
(de)
|
2013-06-25 |
2016-11-16 |
Two Pore Guys Inc |
Quantifizierung multiplexierter biomarker durch nanoporenanalyse von biomarker-polymer-komplexen
|
MX2016000364A
(es)
|
2013-07-12 |
2016-05-09 |
Ophthotech Corp |
Metodos para tratar o prevenir afecciones oftalmologicas.
|
ES2819209T3
(es)
|
2013-07-16 |
2021-04-15 |
Hoffmann La Roche |
Procedimientos de tratamiento del cáncer usando antagonistas de unión al eje de PD-1 e inhibidores de TIGIT
|
US10534003B2
(en)
|
2013-07-17 |
2020-01-14 |
The Johns Hopkins University |
Multi-protein biomarker assay for brain injury detection and outcome
|
US9808472B2
(en)
|
2013-08-12 |
2017-11-07 |
Tokai Pharmaceuticals, Inc. |
Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
|
GB201314485D0
(en)
|
2013-08-13 |
2013-09-25 |
Electrophoretics Ltd |
Materials and methods relating to pancreatic cancer
|
EP2837939A1
(de)
|
2013-08-13 |
2015-02-18 |
Technische Universität München |
Verfahren zum Nachweis von H.pylori-Infektionen
|
BR102013021701A2
(pt)
|
2013-08-26 |
2015-07-28 |
Univ São Paulo Usp |
Polinucleotídeos quimicamente modificados e processo de produção de polinucleotídeos quimicamente modificados
|
AU2014312211A1
(en)
|
2013-08-28 |
2016-03-10 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
GB201315743D0
(en)
|
2013-09-04 |
2013-10-16 |
Maersk Olie & Gas |
Provision and uses of wettability modifiers
|
US11545241B1
(en)
|
2013-09-07 |
2023-01-03 |
Labrador Diagnostics Llc |
Systems and methods for analyte testing and data management
|
CA2920508C
(en)
|
2013-09-09 |
2024-01-16 |
Somalogic, Inc. |
Pdgf and vegf aptamers having improved stability and their use in treating pdgf and vegf mediated diseases and disorders
|
WO2015036618A1
(en)
|
2013-09-16 |
2015-03-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method and pharmaceutical composition for use in the treatment of epilepsy
|
WO2015039187A1
(en)
|
2013-09-18 |
2015-03-26 |
University Of Canberra |
Stem cell modulation ii
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
ES2784234T3
(es)
|
2013-10-08 |
2020-09-23 |
Promedior Inc |
Métodos para el tratamiento de cánceres fibróticos
|
EP3065744B1
(de)
|
2013-11-04 |
2021-04-21 |
Noxxon Pharma AG |
Ein ccl2-antagonist zur behandlung der proteinurie
|
GB201320061D0
(en)
|
2013-11-13 |
2013-12-25 |
Electrophoretics Ltd |
Materials nad methods for diagnosis and prognosis of liver cancer
|
CA2937432A1
(en)
|
2013-11-13 |
2015-05-21 |
Universite de Bordeaux |
Kits-of-parts comprising nucleic acids able to form a kissing complex and their uses thereof
|
RU2732402C2
(ru)
|
2013-11-21 |
2020-09-16 |
Сомалоджик, Инк. |
Цитидин-5-карбоксамид модифицированные нуклеотидные композиции и способы, относящиеся к ним
|
AR093574A1
(es)
|
2013-11-21 |
2015-06-10 |
Consejo Nac De Investig Cientificas Y Tecn (Conicet) |
Aptameros contra la proteina basica de mielina como agentes neuroprotectores
|
DE102013112915A1
(de)
|
2013-11-22 |
2015-05-28 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
DNA-Aptamere, die E- und P-Selektine spezifisch binden
|
JP2016540769A
(ja)
|
2013-12-05 |
2016-12-28 |
サイレンス・セラピューティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
肺特異的送達用手段
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
RU2016128726A
(ru)
|
2013-12-17 |
2018-01-23 |
Дженентек, Инк. |
Способы лечения злокачественных опухолей с использованием антагонистов связывания по оси pd-1 и антитела против cd20
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
WO2015103989A1
(en)
|
2014-01-10 |
2015-07-16 |
Shanghai Birdie Biotech, Inc. |
Compounds and compositions for immunotherapy
|
AU2015213483B2
(en)
|
2014-02-05 |
2020-07-02 |
Deakin University |
Aptamer construct
|
US10619210B2
(en)
|
2014-02-07 |
2020-04-14 |
The Johns Hopkins University |
Predicting response to epigenetic drug therapy
|
CA3152415A1
(en)
|
2014-02-18 |
2015-08-27 |
Somalogic Operating Co., Inc. |
Compositions and methods for detecting microorganisms
|
WO2015135558A1
(en)
|
2014-03-12 |
2015-09-17 |
Curevac Gmbh |
Combination of vaccination and ox40 agonists
|
JP2017509648A
(ja)
|
2014-03-17 |
2017-04-06 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
局所送達用アプタマー
|
US20170107300A1
(en)
|
2014-03-21 |
2017-04-20 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for treatment of immune-related diseases or disorders and/or therapy monitoring
|
MA39776A
(fr)
|
2014-03-24 |
2017-02-01 |
Hoffmann La Roche |
Traitement du cancer avec des antagonistes de c-met et corrélation de ces derniers avec l'expression de hgf
|
US9987298B2
(en)
|
2014-03-24 |
2018-06-05 |
Ribomic Inc. |
Aptamer for FGF2 and use thereof
|
WO2015149006A2
(en)
|
2014-03-27 |
2015-10-01 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
|
ES2845650T3
(es)
|
2014-04-18 |
2021-07-27 |
Acceleron Pharma Inc |
Procedimientos para aumentar los niveles de glóbulos rojos y tratar la drepanocitosis
|
WO2015164616A1
(en)
|
2014-04-24 |
2015-10-29 |
Somalogic, Inc. |
Biomarkers for detection of tuberculosis
|
WO2015164617A1
(en)
|
2014-04-24 |
2015-10-29 |
Somalogic, Inc. |
Tuberculosis biomarkers in urine and uses thereof
|
US9880121B2
(en)
|
2014-04-29 |
2018-01-30 |
Ohmx Corporation |
Bioelectronic binding assay using peak profiling
|
TN2016000553A1
(en)
|
2014-06-13 |
2018-04-04 |
Acceleron Pharma Inc |
Methods and compositions for treating ulcers
|
CN112546231A
(zh)
|
2014-07-09 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗癌症的联合治疗组合物和联合治疗方法
|
DK3166976T3
(da)
|
2014-07-09 |
2022-04-11 |
Birdie Biopharmaceuticals Inc |
Anti-pd-l1-kombinationer til behandling af tumorer
|
JP6673896B2
(ja)
|
2014-07-15 |
2020-03-25 |
ジェネンテック, インコーポレイテッド |
Pd−1軸結合アンタゴニスト及びmek阻害剤を使用した癌を処置するための組成物
|
WO2016025539A1
(en)
|
2014-08-11 |
2016-02-18 |
Ohmx Corporation |
Enzyme triggered redox altering chemical elimination (-trace) assay with multiplexing capabilities
|
EP3182917A1
(de)
|
2014-08-20 |
2017-06-28 |
Memorial Sloan Kettering Cancer Center |
Raman-ausgelöste ablation-/resektionssysteme und verfahren
|
RU2708237C2
(ru)
|
2014-08-22 |
2019-12-05 |
Общество с ограниченной ответственностью "НооГен" |
Модифицированные олигонуклеотиды и способ их получения
|
US10485772B2
(en)
|
2014-08-25 |
2019-11-26 |
EpiAxis Therapeutics Pty Ltd. |
Compositions for modulating cancer stem cells and uses therefor
|
EP4043567A1
(de)
|
2014-08-29 |
2022-08-17 |
Children's Medical Center Corporation |
Verfahren und zusammensetzungen zur krebsbehandlung
|
CN112587672A
(zh)
|
2014-09-01 |
2021-04-02 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
US10274484B2
(en)
|
2014-09-12 |
2019-04-30 |
Mediomics Llc |
Molecular biosensors with a modular design
|
US10222386B2
(en)
|
2014-09-19 |
2019-03-05 |
The Johns Hopkins University |
Biomarkers of congnitive dysfunction
|
US10670611B2
(en)
|
2014-09-26 |
2020-06-02 |
Somalogic, Inc. |
Cardiovascular risk event prediction and uses thereof
|
EP3000483A1
(de)
|
2014-09-29 |
2016-03-30 |
Charité - Universitätsmedizin Berlin |
Mittel und Verfahren zur Diagnose und Behandlung von neurodegenerativen Erkrankungen
|
DE102014114834A1
(de)
|
2014-10-13 |
2016-04-14 |
Centrum Für Angewandte Nanotechnologie (Can) Gmbh |
Nanopartikel enthaltende Polymermizellen in nicht-wässriger Lösung, Methoden zu ihrer Herstellung und ihrer Anwendung
|
WO2016061460A1
(en)
|
2014-10-17 |
2016-04-21 |
Carnegie Mellon University |
Enhanced biomolecule detection assays based on tyramide signal amplification and gammapna probes
|
US11311725B2
(en)
|
2014-10-24 |
2022-04-26 |
Setpoint Medical Corporation |
Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
|
US9816080B2
(en)
|
2014-10-31 |
2017-11-14 |
President And Fellows Of Harvard College |
Delivery of CAS9 via ARRDC1-mediated microvesicles (ARMMs)
|
EP3215536A1
(de)
|
2014-11-06 |
2017-09-13 |
F. Hoffmann-La Roche AG |
Kombinationstherapie mit ox40-bindungsagonisten und tigit-inhibitoren
|
FR3028527A1
(fr)
|
2014-11-13 |
2016-05-20 |
Pivert |
Identification de facteurs de transcription de yarrowia lipolytica
|
WO2016075314A1
(fr)
|
2014-11-13 |
2016-05-19 |
Institut National De La Recherche Agronomique |
Identification de facteurs de transcription de yarrowia lipolytica affectant la production de proteines
|
US10434177B2
(en)
|
2014-11-17 |
2019-10-08 |
Carnegie Mellon University |
Activatable two-component photosensitizers
|
CA2966925C
(en)
|
2014-11-24 |
2023-08-29 |
Somalogic, Inc. |
Nucleic acid compounds for binding growth differentiation factor 11
|
MA41119A
(fr)
|
2014-12-03 |
2017-10-10 |
Acceleron Pharma Inc |
Méthodes de traitement de syndromes myélodysplasiques et d'anémie sidéroblastique
|
US10632193B2
(en)
|
2014-12-24 |
2020-04-28 |
Neximmune, Inc. |
Nanoparticle compositions and methods for immunotherapy
|
WO2016123058A1
(en)
|
2015-01-27 |
2016-08-04 |
Somalogic, Inc. |
Biomarkers for detection of tuberculosis risk
|
SG11201706297RA
(en)
|
2015-02-02 |
2017-09-28 |
Meiragtx Uk Ii Ltd |
Regulation of gene expression by aptamer-mediated modulation of alternative splicing
|
US11406833B2
(en)
|
2015-02-03 |
2022-08-09 |
Setpoint Medical Corporation |
Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
|
TWI708845B
(zh)
|
2015-02-09 |
2020-11-01 |
美商身體邏輯股份有限公司 |
用於結合生長分化因數8之核酸化合物
|
WO2016134365A1
(en)
|
2015-02-20 |
2016-08-25 |
The Johns Hopkins University |
Biomarkers of myocardial injury
|
WO2016135300A1
(en)
|
2015-02-26 |
2016-09-01 |
Qiagen Gmbh |
Efficiency improving methods for gene library generation
|
US9863930B2
(en)
|
2015-02-27 |
2018-01-09 |
Aptascan, Inc. |
Molecular barcoded bi-stable switch
|
US20180245070A1
(en)
|
2015-02-27 |
2018-08-30 |
The University Of Hong Kong |
Dna display and methods thereof
|
US10620185B2
(en)
|
2015-02-27 |
2020-04-14 |
Aptascan, Inc. |
Molecular barcoded bi-stable switch
|
AU2016229076B2
(en)
|
2015-03-09 |
2022-01-20 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
EP3524681A1
(de)
|
2015-03-12 |
2019-08-14 |
The Regents of The University of Michigan |
Inhibitoren des dek-proteins und zugehörige verfahren
|
US10290372B2
(en)
|
2015-03-30 |
2019-05-14 |
Elwha Llc |
Systems and devices for controlling delivery of breast milk supplementation
|
US9968523B2
(en)
|
2015-03-30 |
2018-05-15 |
Elwha Llc |
Systems and devices for controlling delivery of breast milk supplementation
|
US10016341B2
(en)
|
2015-03-30 |
2018-07-10 |
Elwha Llc |
Systems and devices for controlling delivery of breast milk supplementation
|
WO2016158851A1
(ja)
|
2015-03-30 |
2016-10-06 |
日産化学工業株式会社 |
血管内皮増殖因子受容体に結合する核酸アプタマー
|
US9925122B2
(en)
|
2015-03-30 |
2018-03-27 |
Elwha Llc |
Systems and methods for controlling delivery of breast milk supplementation
|
BR112017021256A2
(pt)
|
2015-04-03 |
2018-06-26 |
Abbott Laboratories |
dispositivos e métodos para a análise de amostras
|
CN107690582B
(zh)
|
2015-04-03 |
2023-10-20 |
雅培制药有限公司 |
用于样品分析的装置和方法
|
MA41919A
(fr)
|
2015-04-06 |
2018-02-13 |
Acceleron Pharma Inc |
Hétéromultimères alk4:actriib et leurs utilisations
|
MA41916A
(fr)
|
2015-04-06 |
2021-04-14 |
Acceleron Pharma Inc |
Hétéromultimères de récepteur de type i et de type ii de la superfamille de tgf-bêta et leurs utilisations
|
KR20170135966A
(ko)
|
2015-04-13 |
2017-12-08 |
맥스시티 인코포레이티드 |
게놈 dna를 변형시키기 위한 방법 및 조성물
|
WO2016182967A1
(en)
|
2015-05-08 |
2016-11-17 |
Somalogic, Inc. |
Biomarkers for detection of tuberculosis risk
|
WO2016196218A1
(en)
|
2015-05-31 |
2016-12-08 |
Curegenix Corporation |
Combination compositions for immunotherapy
|
US10933049B2
(en)
|
2015-06-03 |
2021-03-02 |
The University Of Queensland |
Mobilizing agents and uses therefor
|
WO2016196945A1
(en)
|
2015-06-05 |
2016-12-08 |
Regulus Therapeutics Inc. |
Non-alcoholic fatty liver disease biomarkers
|
PL3313443T3
(pl)
|
2015-06-25 |
2023-11-06 |
Immunomedics, Inc. |
Łączenie przeciwciał anty-hla-dr lub anty-trop-2 z inhibitorami mikrotubuli, inhibitorami parp, 5 inhibitorami kinazy brutona lub inhibitorami 3-kinazy fosfoinozytydu istotnie poprawia wynik terapeutyczny nowotworu
|
CA2991045A1
(en)
|
2015-06-29 |
2017-01-05 |
Caris Science, Inc. |
Therapeutic oligonucleotides binding c1q
|
WO2017004463A1
(en)
|
2015-07-01 |
2017-01-05 |
Abbott Laboratories |
Devices and methods for sample analysis
|
EP3328427A4
(de)
|
2015-07-27 |
2018-12-12 |
The General Hospital Corporation |
Antikörperderivate mit bedingt aktivierter effektorfunktion
|
US10941176B2
(en)
|
2015-07-28 |
2021-03-09 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
EP3331557B1
(de)
|
2015-08-04 |
2021-04-07 |
Duke University |
Genetisch codierte intrinsisch ungeordnete stealth-polymere zur freisetzung und verfahren zur verwendung davon
|
CN108348578B
(zh)
|
2015-08-04 |
2022-08-09 |
阿塞勒隆制药公司 |
用于治疗骨髓增生性病症的方法
|
WO2017176265A1
(en)
|
2016-04-06 |
2017-10-12 |
Mayo Foundation For Medical Education And Research |
Carrier-binding agent compositions and methods of making and using the same
|
US10407484B2
(en)
|
2015-09-02 |
2019-09-10 |
The Regents Of The University Of Colorado, A Body Corporate |
Compositions and methods for modulating T-cell mediated immune response
|
EP3344805B1
(de)
|
2015-09-04 |
2021-12-01 |
Neoventures Biotechnology Inc. |
Verfahren zur auswahl von aptameren für ungebundene targets
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
KR102604025B1
(ko)
|
2015-09-09 |
2023-11-21 |
소마로직 오퍼레이팅 컴퍼니, 인코포레이티드 |
개인별 약물 치료 계획의 개발 방법 및 단백질체 프로파일을 기반으로 하는 표적 약물 개발 방법
|
US11702477B2
(en)
|
2015-11-06 |
2023-07-18 |
Orionis Biosciences BV |
Bi-functional chimeric proteins and uses thereof
|
JP2018535224A
(ja)
|
2015-11-19 |
2018-11-29 |
アスクレピクス セラピューティクス エルエルシー. |
抗血管新生、抗リンパ管新生及び抗浮腫特性を有するペプチド及びナノ粒子製剤
|
CN108697793B
(zh)
|
2015-11-23 |
2023-08-01 |
阿塞勒隆制药公司 |
治疗眼睛疾病的方法
|
WO2017089593A1
(en)
|
2015-11-26 |
2017-06-01 |
Universite Paris Descartes |
Inhibitors for treating or preventing a pulmonary arterial hypertension in systemic sclerosis patients and method for diagnosing said disease
|
JPWO2017094733A1
(ja)
|
2015-11-30 |
2018-09-13 |
日産化学株式会社 |
分子標的医薬に結合するdnaアプタマー及びそれを用いる分子標的医薬の検出方法
|
GB201522186D0
(en)
|
2015-12-16 |
2016-01-27 |
Singapore Health Services Pte Ltd And Nat University Of Singapore The |
Treatment of fibrosis
|
US11752213B2
(en)
|
2015-12-21 |
2023-09-12 |
Duke University |
Surfaces having reduced non-specific binding and antigenicity
|
DE102016100039A1
(de)
|
2016-01-04 |
2017-07-06 |
Universitätsklinikum Hamburg-Eppendorf (UKE) |
α6-Integrin bindendes DNA-Aptamer
|
US10596367B2
(en)
|
2016-01-13 |
2020-03-24 |
Setpoint Medical Corporation |
Systems and methods for establishing a nerve block
|
WO2017127756A1
(en)
|
2016-01-20 |
2017-07-27 |
Setpoint Medical Corporation |
Control of vagal stimulation
|
US10314501B2
(en)
|
2016-01-20 |
2019-06-11 |
Setpoint Medical Corporation |
Implantable microstimulators and inductive charging systems
|
JP2019506159A
(ja)
|
2016-01-20 |
2019-03-07 |
ヴィトリサ セラピューティクス, インコーポレイテッド |
D因子を阻害するための組成物および方法
|
US11471681B2
(en)
|
2016-01-20 |
2022-10-18 |
Setpoint Medical Corporation |
Batteryless implantable microstimulators
|
EP4012416A1
(de)
|
2016-01-22 |
2022-06-15 |
Purdue Research Foundation |
Verwendung eines markierungssystems mit geladener masse zum nachweis von zielanalyten
|
US10583304B2
(en)
|
2016-01-25 |
2020-03-10 |
Setpoint Medical Corporation |
Implantable neurostimulator having power control and thermal regulation and methods of use
|
CN109071632B
(zh)
|
2016-02-05 |
2022-12-30 |
奥里尼斯生物科学私人有限公司 |
靶向性治疗剂及其用途
|
BR112018014842A8
(pt)
|
2016-02-08 |
2022-10-18 |
Somalogic Inc |
Métodos para determinar se um indivíduo tem doença hepática gordurosa não alcoólica (nafld) inflamação lobular, fibrose e hepatócitos balonizados referência cruzada aos pedidos relacionados
|
CA3016849A1
(en)
|
2016-03-07 |
2017-09-14 |
Vib Vzw |
Cd20 binding single domain antibodies
|
CA3018066A1
(en)
|
2016-03-18 |
2017-09-21 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
US11355328B2
(en)
|
2016-04-13 |
2022-06-07 |
Purdue Research Foundation |
Systems and methods for isolating a target ion in an ion trap using a dual frequency waveform
|
CN109121413A
(zh)
|
2016-04-14 |
2019-01-01 |
弗莱德哈钦森癌症研究中心 |
使用靶向核酸纳米载体编程治疗性细胞的组合物和方法
|
WO2017187426A1
(en)
|
2016-04-29 |
2017-11-02 |
Aptamir Therapeutics, Inc. |
Inhibition of mir-22 mirna by apt-110
|
WO2017195137A1
(en)
|
2016-05-10 |
2017-11-16 |
Nicolas Arab |
Compositions and methods for identifying, quantifying, and/or characterizing an analyte
|
US11236141B2
(en)
|
2016-05-13 |
2022-02-01 |
Orionis Biosciences BV |
Targeted mutant interferon-beta and uses thereof
|
WO2017194782A2
(en)
|
2016-05-13 |
2017-11-16 |
Orionis Biosciences Nv |
Therapeutic targeting of non-cellular structures
|
AU2017271579B2
(en)
|
2016-05-25 |
2023-10-19 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
WO2017210476A1
(en)
|
2016-06-01 |
2017-12-07 |
Duke University |
Nonfouling biosensors
|
US10829563B2
(en)
|
2016-06-16 |
2020-11-10 |
INSERM (Institute National de la Santé et de la Recherche Médicale) |
Method of screening a candidate compound for activity as an elastase 2A (ELA2A) inhibitor
|
EP3263706A1
(de)
|
2016-06-28 |
2018-01-03 |
Centre National De La Recherche Scientifique (Cnrs) |
Auf snat7 abzielende wirkstoffe zur behandlung von erkrankungen im zusammenhang mit der zellstoffwechselumprogrammierung
|
US20200308631A1
(en)
|
2016-06-30 |
2020-10-01 |
Biois Co., Ltd |
Double-stranded nucleic acid signal probe and method for detecting target molecule using same
|
BR112018075869A8
(pt)
|
2016-07-01 |
2022-10-18 |
Somalogic Inc |
Oligonucleotídeos que compreendem nucleosídeos modificados
|
EP3264092A1
(de)
|
2016-07-01 |
2018-01-03 |
Centogene AG |
Verwendung von lyso-gb1 als krankheitsassoziiertes ziel
|
DK3496739T3
(da)
|
2016-07-15 |
2021-05-10 |
Acceleron Pharma Inc |
Sammensætninger omfattende actriia-polypeptider til brug i behandlingen af pulmonal hypertension
|
US11041863B2
(en)
|
2016-07-21 |
2021-06-22 |
Retinal Solutions Llc |
Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction
|
EP3490582A4
(de)
|
2016-07-27 |
2020-04-01 |
Acceleron Pharma Inc. |
Verfahren und zusammensetzungen zur behandlung von myelofibrose
|
EP3491135A1
(de)
|
2016-07-28 |
2019-06-05 |
Laboratoire Français du Fractionnement et des Biotechnologies |
Verfahren zur gewinnung von aptameren
|
US9927441B1
(en)
|
2016-07-29 |
2018-03-27 |
X Development Llc |
Combinatorial methods for aptamer based proteomics
|
JP7089502B2
(ja)
|
2016-08-03 |
2022-06-22 |
メイラジーティーエックス・ユーケー・ザ・セカンド・リミテッド |
アプタマーのためのハイスループット細胞系スクリーニング
|
KR20190039788A
(ko)
|
2016-08-22 |
2019-04-15 |
닛산 가가쿠 가부시키가이샤 |
E-카드헤린 결합형 핵산 앱타머를 사용하는 세포 스캐폴드 재료
|
JP2019526579A
(ja)
|
2016-09-01 |
2019-09-19 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチMayo Foundation For Medical Education And Research |
T細胞癌を標的とする為の方法及び組成物
|
KR20220151022A
(ko)
|
2016-09-01 |
2022-11-11 |
메이오 파운데이션 포 메디칼 에쥬케이션 앤드 리써치 |
암 치료용 담체-pd-l1 결합제 조성물
|
JP7025412B2
(ja)
|
2016-09-06 |
2022-02-24 |
マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ |
パクリタキセル-アルブミン-結合剤組成物並びに該組成物の使用及び製造方法
|
US11730823B2
(en)
|
2016-10-03 |
2023-08-22 |
President And Fellows Of Harvard College |
Delivery of therapeutic RNAs via ARRDC1-mediated microvesicles
|
EA201990868A1
(ru)
|
2016-10-04 |
2019-09-30 |
Асклепикс Терапьютикс, Инк. |
СОЕДИНЕНИЯ И СПОСОБЫ АКТИВАЦИИ СИГНАЛЬНОЙ СИСТЕМЫ Tie2
|
CN109863391B
(zh)
|
2016-10-05 |
2021-11-05 |
雅培实验室 |
用于样品分析的装置和方法
|
CN110198743B
(zh)
|
2016-10-05 |
2023-07-18 |
艾科赛扬制药股份有限公司 |
用于治疗肾脏疾病的组合物和方法
|
US11198129B2
(en)
|
2016-10-05 |
2021-12-14 |
Abbott Laboratories |
Devices and methods for sample analysis
|
AU2017341927B2
(en)
|
2016-10-14 |
2021-12-16 |
CNS Biosciences, Inc. |
Treating neuropathic pain in spinal cord injured individuals
|
CN110114368A
(zh)
|
2016-10-24 |
2019-08-09 |
奥睿尼斯生物科学公司 |
靶向突变干扰素-γ及其用途
|
WO2018079864A1
(ko)
|
2016-10-24 |
2018-05-03 |
김성천 |
TNF-α 결합 압타머 및 그것의 치료적 용도
|
EP3315125A1
(de)
|
2016-10-31 |
2018-05-02 |
Silence Therapeutics (London) Ltd |
Lipidnanopartikelformulierung
|
CN110945143A
(zh)
|
2016-11-02 |
2020-03-31 |
拜欧亿思有限公司 |
利用下一代测序方法的靶蛋白的聚类定量方法及其用途
|
EP3332812A1
(de)
|
2016-12-07 |
2018-06-13 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Nukleinsäurebasierte anordnung und verwendung der anordnung in der krebstherapie
|
WO2018115083A1
(en)
|
2016-12-21 |
2018-06-28 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method of treatment of gut diseases such as irritable bowel syndrome (ibs)
|
WO2018132732A1
(en)
|
2017-01-12 |
2018-07-19 |
Duke University |
Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
|
WO2018136827A1
(en)
|
2017-01-20 |
2018-07-26 |
Vitrisa Therapeutics, Inc. |
Stem-loop compositions and methods for inhibiting factor d
|
EP3577133A1
(de)
|
2017-02-06 |
2019-12-11 |
Orionis Biosciences NV |
Gezielte chimäre proteine und verwendungen davon
|
JP2020505955A
(ja)
|
2017-02-06 |
2020-02-27 |
オリオンズ バイオサイエンス インコーポレイテッド |
標的化改変型インターフェロン及びその使用
|
EP3580230A1
(de)
|
2017-02-07 |
2019-12-18 |
VIB vzw |
Auf immunzellen gerichtete bispezifische chimäre proteine und verwendungen davon
|
SG11201907700XA
(en)
|
2017-02-21 |
2019-09-27 |
Meiragtx Uk Ii Limited |
Regulation of gene expression by aptamer-mediated accessibility of polyadenylation signals
|
WO2018213320A1
(en)
|
2017-05-15 |
2018-11-22 |
Duke University |
Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
|
WO2019005503A1
(en)
|
2017-06-29 |
2019-01-03 |
Rutgers, The State University Of New Jersey |
COMPOSITIONS AND METHODS TARGETING G12 SIGNALING FOR BRONCHODILATORY THERAPY
|
US11680083B2
(en)
|
2017-06-30 |
2023-06-20 |
Duke University |
Order and disorder as a design principle for stimuli-responsive biopolymer networks
|
EP3428184A1
(de)
|
2017-07-09 |
2019-01-16 |
Universitätsklinikum Hamburg-Eppendorf |
Mittel zur behandlung von herz-kreislauf-erkrankung
|
WO2019028427A1
(en)
|
2017-08-03 |
2019-02-07 |
Asclepix Therapeutics, Llc. |
METHODS OF IDENTIFYING AND PREPARING PHARMACEUTICAL AGENTS TO ACTIVATE TIE2 RECEPTOR
|
WO2019032811A1
(en)
|
2017-08-09 |
2019-02-14 |
The Procter & Gamble Company |
APTAMERS FOR COMPOSITIONS OF CONSUMER PRODUCTS
|
EP3668402A4
(de)
|
2017-08-14 |
2021-05-19 |
Setpoint Medical Corporation |
Vagusnervstimulationsvorscreening-test
|
US10934549B2
(en)
|
2017-08-18 |
2021-03-02 |
University Of Iowa Research Foundation |
Nucleic acid aptamers
|
US20200268837A1
(en)
|
2017-09-20 |
2020-08-27 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and pharmaceutical compositions for modulating autophagy
|
NL2019739B1
(en)
|
2017-10-16 |
2019-04-23 |
Academisch Ziekenhuis Leiden |
Means and methods for treating muscle degeneration
|
US11473089B2
(en)
|
2017-11-09 |
2022-10-18 |
Ribomic Inc. |
Aptamer for ADAMTS5 and use for aptamer for ADAMTS5
|
KR20200090869A
(ko)
|
2017-11-30 |
2020-07-29 |
가부시키가이샤 리보믹 |
항-키마제 압타머 및 그의 용도
|
US20200332296A1
(en)
|
2017-12-28 |
2020-10-22 |
Nuclixbio |
Aptamer template and method for preparing aptamer by using same
|
EP3521828A1
(de)
|
2018-01-31 |
2019-08-07 |
Centogene AG |
Verfahren zur diagnose eines hereditären angioödems
|
WO2019152979A1
(en)
|
2018-02-05 |
2019-08-08 |
Orionis Biosciences, Inc. |
Fibroblast binding agents and use thereof
|
HUE064471T2
(hu)
|
2018-03-05 |
2024-03-28 |
Klinikum Rechts Der Isar Der Technischen Univ Muenchen |
Daganatok kezelése onkolitikus adenovírus és CDK4/6 inhibitor kombinációjával
|
US10481155B2
(en)
|
2018-03-09 |
2019-11-19 |
Somalogic, Inc. |
Proteomic assay using quantum sensors
|
WO2019175380A2
(en)
|
2018-03-16 |
2019-09-19 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigenic peptides deriving from secretogranin v and uses thereof for the diagnosis and treatment of type 1 diabetes
|
EP3765064A1
(de)
|
2018-03-16 |
2021-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Pcsk2-abgeleitete antigene peptide und verwendungen davon zur diagnose und behandlung von diabetes typ 1
|
EP3765053A2
(de)
|
2018-03-16 |
2021-01-20 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antigene peptide aus urocortin 3 und verwendungen davon zur diagnose und behandlung von typ-1-diabetes
|
US20210140977A1
(en)
|
2018-04-16 |
2021-05-13 |
University Of Cape Town |
A three-protein proteomic biomarker for prospective determination of risk for development of active tuberculosis
|
US11660443B2
(en)
|
2018-04-20 |
2023-05-30 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via electrical trigeminal nerve stimulation
|
FR3081169B1
(fr)
|
2018-05-15 |
2020-06-19 |
Messenger Biopharma |
Substitution de la coiffe des arn messagers par deux sequences d'arn introduites a leur extremite 5'
|
WO2019236632A1
(en)
|
2018-06-04 |
2019-12-12 |
Avon Products. Inc. |
Protein biomarkers for identifying and treating aging skin and skin conditions
|
US11384357B2
(en)
|
2018-06-29 |
2022-07-12 |
The Procter And Gamble Company |
Aptamers for personal care applications
|
EP3814505A1
(de)
|
2018-06-29 |
2021-05-05 |
The Procter & Gamble Company |
Aptamere für haarpflegeanwendungen
|
WO2020028806A1
(en)
|
2018-08-02 |
2020-02-06 |
Duke University |
Dual agonist fusion proteins
|
US11260229B2
(en)
|
2018-09-25 |
2022-03-01 |
The Feinstein Institutes For Medical Research |
Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
|
EP3860451A4
(de)
|
2018-10-02 |
2022-08-31 |
Wearoptimo Pty Ltd |
System zur bestimmung des flüssigkeitsstandes in einem biologischen subjekt
|
US20210317456A1
(en)
|
2018-10-15 |
2021-10-14 |
Somalogic, Inc. |
Nucleic Acid Compounds for Binding Immunoglobulin G
|
WO2020079248A1
(en)
|
2018-10-19 |
2020-04-23 |
Neoneuro |
Early detection of precursor of alzheimer's disease
|
JP7332694B2
(ja)
|
2018-12-04 |
2023-08-23 |
エフ. ホフマン-ラ ロシュ アーゲー |
細胞標的の空間指向性量子バーコード化
|
WO2020115223A1
(en)
|
2018-12-05 |
2020-06-11 |
Katholieke Universiteit Leuven |
S100a4 as a marker of treatment with spironolactone, pioglitazone and metformin
|
WO2020132269A1
(en)
|
2018-12-20 |
2020-06-25 |
KSQ Therapeutics, Inc. |
Substituted pyrazolopyrimidines and substituted purines and their use as ubiquitin-specific-processing protease 1 (usp1) inhibitors
|
US11883401B2
(en)
|
2019-01-08 |
2024-01-30 |
Duke University |
Compositions for the treatment of pathogenic- and/or chemical-induced lung injury and for the treatment of cancer and methods of using same
|
WO2020144535A1
(en)
|
2019-01-08 |
2020-07-16 |
Aduro Biotech Holdings, Europe B.V. |
Methods and compositions for treatment of multiple myeloma
|
EP3914621A1
(de)
|
2019-01-21 |
2021-12-01 |
Singapore Health Services Pte. Ltd. |
Behandlung von hepatotoxizität
|
US11254736B2
(en)
|
2019-02-15 |
2022-02-22 |
Integral Molecular, Inc. |
Antibodies comprising a common light chain and uses thereof
|
US11248046B2
(en)
|
2019-02-15 |
2022-02-15 |
Integral Molecular, Inc. |
Claudin 6 antibodies and uses thereof
|
GB201902419D0
(en)
|
2019-02-22 |
2019-04-10 |
Singapore Health Serv Pte Ltd |
Treatment of kidney injury
|
KR20210142694A
(ko)
|
2019-03-22 |
2021-11-25 |
소마로직, 인크. |
생물학적 복합 매트릭스에서 샘플-간 피분석물 변동성 감소
|
AU2020252269A1
(en)
|
2019-04-04 |
2021-12-09 |
Carmentix Pte. Ltd. |
Biomarker pairs of preterm birth
|
WO2020201521A1
(en)
|
2019-04-04 |
2020-10-08 |
Carmentix Pte. Ltd. |
Biomarker pairs of preterm birth
|
US20220193048A1
(en)
|
2019-04-05 |
2022-06-23 |
Universite De Bretagne Occidentale |
Protease-activated receptor-2 inhibitors for the treatment of sensory neuropathy induced by a marine neurotoxic poisoning
|
EP3956451A1
(de)
|
2019-04-16 |
2022-02-23 |
The Procter & Gamble Company |
Aptamere für geruchsunterdrückungsanwendungen
|
GB201906291D0
(en)
|
2019-05-03 |
2019-06-19 |
Singapore Health Serv Pte Ltd |
Treatment and prevention of metabolic diseases
|
MX2021013356A
(es)
|
2019-05-03 |
2022-03-11 |
Singapore Health Serv Pte Ltd |
Tratamiento y prevencion de enfermedades metabolicas.
|
SG11202111365QA
(en)
|
2019-05-17 |
2021-11-29 |
Somalogic Inc |
Controlling intersample analyte variability in complex biological matrices
|
GB201908544D0
(en)
|
2019-06-14 |
2019-07-31 |
Nat Univ Singapore |
Treatment and prevention of disease mediated by wwp2
|
US11198908B2
(en)
|
2019-06-17 |
2021-12-14 |
Biorchestra Co., Ltd. |
Method for diagnosis of Alzheimer's disease using microRNA
|
KR102113078B1
(ko)
|
2019-07-05 |
2020-05-20 |
광주과학기술원 |
압타머의 선별 방법
|
US11512314B2
(en)
|
2019-07-12 |
2022-11-29 |
Duke University |
Amphiphilic polynucleotides
|
WO2021019196A1
(en)
|
2019-07-31 |
2021-02-04 |
University Of Dundee |
Analyte biosensing
|
WO2021024020A1
(en)
|
2019-08-06 |
2021-02-11 |
Astellas Pharma Inc. |
Combination therapy involving antibodies against claudin 18.2 and immune checkpoint inhibitors for treatment of cancer
|
EP4010707A1
(de)
|
2019-08-07 |
2022-06-15 |
Abbott Laboratories |
Verfahren zur detektion von teststörsubstanzen und zur erhöhung des dynamikbereichs
|
US20220291223A1
(en)
|
2019-08-07 |
2022-09-15 |
Abbott Laboratories |
Chemiluminescent compounds for multiplexing
|
CN114641692A
(zh)
|
2019-09-03 |
2022-06-17 |
私募蛋白质体操作有限公司 |
心血管风险事件预测及其用途
|
AU2020342594A1
(en)
|
2019-09-05 |
2022-03-10 |
Klinikum Rechts Der Isar Der Technischen Universität München |
Treatment of tumors by a combination of an oncolytic adenovirus, a CDK4/6 inhibitor and a further therapeutically active agent
|
WO2021076713A1
(en)
|
2019-10-16 |
2021-04-22 |
Somalogic, Inc. |
Nucleic acid compounds that bind to retinoic acid-inducible gene i protein
|
MX2022007680A
(es)
|
2019-12-20 |
2022-09-26 |
Curevac Ag |
Nanoparticulas lipidicas para administracion de acidos nucleicos.
|
WO2021142200A1
(en)
|
2020-01-10 |
2021-07-15 |
Somalogic, Inc. |
Methods of determining impaired glucose tolerance
|
IL295064A
(en)
|
2020-02-10 |
2022-09-01 |
Somalogic Operating Co Inc |
Biomarkers for non-alcoholic fatty liver disease (nash) and their uses
|
WO2021178923A1
(en)
|
2020-03-06 |
2021-09-10 |
Drinksavvy, Inc. |
Devices and methods for detecting a target analyte of interest
|
EP4118432A1
(de)
|
2020-03-10 |
2023-01-18 |
Abbott Laboratories |
Verfahren zur tröpfchenladung in nanovertiefungen
|
GB202004514D0
(en)
|
2020-03-27 |
2020-05-13 |
Inst De Medicina Molecular Joaeo Lobo Antunes |
Treatment of Immunosuppressive Cancer
|
GB2594094A
(en)
|
2020-04-17 |
2021-10-20 |
Pockit Diagnostics Ltd |
Method for diagnosing stroke caused by large vessel occlusion
|
JP2023526914A
(ja)
|
2020-05-07 |
2023-06-26 |
インターオリゴ・コーポレイション |
新規核酸リガンド及びその識別方法
|
JP2023526080A
(ja)
|
2020-05-21 |
2023-06-20 |
ザ・フェインステイン・インスティチュート・フォー・メディカル・リサーチ |
迷走神経刺激のためのシステムおよび方法
|
TW202214861A
(zh)
|
2020-06-17 |
2022-04-16 |
日商力博美科股份有限公司 |
針對il-21之適體及其用途
|
GB202009292D0
(en)
|
2020-06-18 |
2020-08-05 |
Singapore Health Serv Pte Ltd |
Treatment and prevention of disease caused by type IV collagen dysfunction
|
WO2021262911A1
(en)
|
2020-06-25 |
2021-12-30 |
The Procter & Gamble Company |
Aptamers for personal health care applications
|
IL298993A
(en)
|
2020-07-07 |
2023-02-01 |
BioNTech SE |
Therapeutic RNA for HPV positive cancer
|
EP4200250A1
(de)
|
2020-08-18 |
2023-06-28 |
Regenacellx.SL |
Zusammensetzungen und verfahren zum nachweis von sars-cov-2-spike-protein
|
WO2022051414A1
(en)
|
2020-09-02 |
2022-03-10 |
Mayo Foundation For Medical Education And Research |
Antibody-nanoparticle complexes and methods for making and using the same
|
EP4225922A1
(de)
|
2020-10-07 |
2023-08-16 |
Centre National de la Recherche Scientifique (CNRS) |
Verfahren zur selektion von aptameren, riboschaltern und desoxyriboschaltern
|
US20230393146A1
(en)
|
2020-10-20 |
2023-12-07 |
Somalogic Operating Co., Inc. |
Cardiovascular Event Risk Prediction
|
US11718624B2
(en)
|
2020-10-30 |
2023-08-08 |
KSQ Therapeutics, Inc. |
Solid state forms of substituted pyrazolopyrimidines and uses thereof
|
GB202017244D0
(en)
|
2020-10-30 |
2020-12-16 |
Nat Univ Singapore |
Methods to extend health-span and treat age-related diseases
|
CN112779320B
(zh)
*
|
2020-12-04 |
2023-07-14 |
深圳市易基因科技有限公司 |
多区域dna甲基化检测探针设计及其检测方法
|
JP2024501627A
(ja)
|
2020-12-14 |
2024-01-15 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
インヒビンサブユニットβE(INHBE)阻害剤による代謝障害及び心血管疾患の治療方法
|
WO2022131350A1
(ja)
|
2020-12-18 |
2022-06-23 |
タグシクス・バイオ株式会社 |
Dnaアプタマーのスクリーニングに使用可能な新規人工塩基を有するデオキシリボヌクレオシド、デオキシリボヌクレオチド、およびこれを含有する核酸
|
WO2022135666A1
(en)
|
2020-12-21 |
2022-06-30 |
BioNTech SE |
Treatment schedule for cytokine proteins
|
WO2022135667A1
(en)
|
2020-12-21 |
2022-06-30 |
BioNTech SE |
Therapeutic rna for treating cancer
|
TW202245808A
(zh)
|
2020-12-21 |
2022-12-01 |
德商拜恩迪克公司 |
用於治療癌症之治療性rna
|
US20240083990A1
(en)
|
2021-01-26 |
2024-03-14 |
Universite Brest Bretagne Occidentale |
Novel stim1 splicing variants and uses thereof
|
TW202304506A
(zh)
|
2021-03-25 |
2023-02-01 |
日商安斯泰來製藥公司 |
涉及抗claudin 18.2抗體的組合治療以治療癌症
|
CA3214113A1
(en)
|
2021-04-13 |
2022-10-20 |
Cate FOWLER |
Modified nucleosides
|
CA3214181A1
(en)
|
2021-04-14 |
2022-10-20 |
Amy D. GELINAS |
Nucleic acid compounds that bind coronavirus proteins
|
US11578320B2
(en)
|
2021-04-27 |
2023-02-14 |
Singular Genomics Systems, Inc. |
High density sequencing and multiplexed priming
|
WO2022266031A2
(en)
|
2021-06-15 |
2022-12-22 |
Somalogic Operating Co., Inc. |
Renal insufficiency prediction and uses thereof
|
WO2023278502A1
(en)
|
2021-06-30 |
2023-01-05 |
Somalogic Operating Co., Inc. |
Renal health determination and uses thereof
|
WO2023285552A1
(en)
|
2021-07-13 |
2023-01-19 |
BioNTech SE |
Multispecific binding agents against cd40 and cd137 in combination therapy for cancer
|
WO2023006765A1
(en)
|
2021-07-26 |
2023-02-02 |
Boehringer Ingelheim International Gmbh |
Treatment and prevention of alcoholic liver disease
|
WO2023014196A1
(ko)
|
2021-08-06 |
2023-02-09 |
인터올리고 주식회사 |
올리고뉴클레오티드를 유효성분으로 포함하는 삼중음성유방암을 예방 또는 치료하기 위한 약학적 조성물
|
CA3230031A1
(en)
|
2021-09-03 |
2023-03-09 |
Patrick Baumhof |
Novel lipid nanoparticles for delivery of nucleic acids
|
WO2023039522A1
(en)
|
2021-09-10 |
2023-03-16 |
Guardian Therapeutics, Llc |
Fatty acid conjugates of nucleic acids
|
WO2023057534A1
(en)
|
2021-10-06 |
2023-04-13 |
Genmab A/S |
Multispecific binding agents against pd-l1 and cd137 in combination
|
WO2023057535A1
(en)
|
2021-10-06 |
2023-04-13 |
Genmab A/S |
Multispecific binding agents against pd-l1 and cd137 in combination with anti pd-1 antibodies for treating cancers
|
WO2023059854A1
(en)
|
2021-10-07 |
2023-04-13 |
Somalogic Operating Co., Inc. |
Lung cancer prediction and uses thereof
|
TW202333802A
(zh)
|
2021-10-11 |
2023-09-01 |
德商拜恩迪克公司 |
用於肺癌之治療性rna(二)
|
WO2023066881A1
(en)
|
2021-10-18 |
2023-04-27 |
Astrazeneca Ab |
Inhibition of map3k15 for treating and preventing diabetes
|
WO2023083439A1
(en)
|
2021-11-09 |
2023-05-19 |
BioNTech SE |
Tlr7 agonist and combinations for cancer treatment
|
WO2023114799A1
(en)
|
2021-12-14 |
2023-06-22 |
The Procter & Gamble Company |
Aptamers for personal health care applications
|
WO2023111196A1
(en)
|
2021-12-16 |
2023-06-22 |
Singapore Health Services Pte. Ltd. |
Treatment and prevention of glomerular disease
|
WO2023141248A1
(en)
|
2022-01-21 |
2023-07-27 |
Somalogic Operating Co., Inc. |
Methods for sample quality assessment
|
WO2023154452A1
(en)
|
2022-02-11 |
2023-08-17 |
Waypoint Bio, Inc. |
Cellular staining probes for analyte detection
|
WO2023183873A1
(en)
|
2022-03-24 |
2023-09-28 |
Mensura Health Inc. |
Aptamers and uses thereof
|
WO2023211769A1
(en)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Methods for sample quality assessment
|
WO2023211770A1
(en)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Methods for sample quality assessment
|
WO2023211773A1
(en)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Methods for sample quality assessment
|
WO2023211771A1
(en)
|
2022-04-24 |
2023-11-02 |
Somalogic Operating Co., Inc. |
Methods for sample quality assessment
|
WO2023235858A1
(en)
|
2022-06-03 |
2023-12-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Engineered cell-penetrating antiviral compound
|
WO2024008755A1
(en)
|
2022-07-04 |
2024-01-11 |
Vib Vzw |
Blood-cerebrospinal fluid barrier crossing antibodies
|
WO2024015486A1
(en)
|
2022-07-14 |
2024-01-18 |
Somalogic Operating Co., Inc. |
Methods for sample quality assessment
|
WO2024015485A1
(en)
|
2022-07-14 |
2024-01-18 |
Somalogic Operating Co., Inc. |
Methods of assessing dementia risk
|
WO2024026474A1
(en)
|
2022-07-29 |
2024-02-01 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
WO2024030432A1
(en)
|
2022-08-01 |
2024-02-08 |
Gensaic, Inc. |
Therapeutic phage-derived particles
|
GB202212077D0
(en)
|
2022-08-18 |
2022-10-05 |
Tribune Therapeutics Ab |
Agents that inhibit ccn ligand-induced signalling for treating disease
|
WO2024064322A2
(en)
|
2022-09-23 |
2024-03-28 |
Somalogic Operating Co., Inc. |
Methods of assessing tobacco use status
|